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ABSTRACT
The evolution of surgical approaches and procedures over the past century
is remarkable. The brutality and risks associated with operations has substantially
decreased, whereas the procedures themselves became safe and efficient.
Nevertheless, none of the surgical procedures is completely safe, reliable and
painless, which often leads to the patients experiencing post-operative
discomforts. These discomforts are usually resolved within several days after the
operation, and do not require any additional prophylaxes or treatments. However,
in some cases, surgeries are followed by post-operative complications that cannot
be resolved without additional medical attention. Shock, hemorrhage, deep vein
thrombosis, pulmonary complications, urinary retention, reaction to anesthesia are
among the most devastating post-surgical complications. However, the most
important ones are infections and chronic pain. The emergence of these
complications becomes more acute when surgical implants are used during the
operation. Implant-associated complications often require specific medical
treatment; in some cases, additional surgery or implant removal is necessary to
resolve the complication. All these negatively affect patients’ quality of life and put
an additional economic pressure on a healthcare system. Therefore, the
development of approaches to decrease the burden of surgical implant-associated
complications, in particular chronic pain and infections, is an important objective
and was addressed in the present study.
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The first part of the dissertation is focused on the post-surgical infections.
We addressed this problem in the example of orthopaedic Kirchner wires, bearing
in mind high incidence rate of the pin-site infections, which can reach up to 100%
for longer implant residence times. Therefore, novel approaches to prevention of
microbial infections after insertion of orthopedic external fixators are in great
demand. Monolaurin is an antimicrobial agent with known safety record, broadly
used in food and cosmetic industries; however, its use in antimicrobial coatings of
medical devices has not been studied in much detail. Here, we report the use of
monolaurin as an antibacterial coating on external fixators for the first time. The
monolaurin-coated Kirschner wires (K-wires) showed excellent antibacterial
properties against three different bacterial strains - Staphylococcus aureus,
methicillin-resistant

Staphylococcus

aureus

(MRSA)

and

Staphylococcus

epidermidis. Both planktonic and adherent bacteria were completely eliminated,
when brought in contact with monolaurin-coated K-wires. At the same time,
monolaurin-coated K-wires did not show any observable cytotoxicity with mouse
osteoblast cell cultures. Overall, monolaurin-coated K-wires could be promising as
potent antimicrobial materials for orthopaedic surgery.
In the second part of the dissertation we address post-operative chronic pain
in the example of hernia repair meshes. First, we focused on studying the
mechanism of the development of post-hernioplasty chronic pain. Despite the
relative safety of the procedure, hernia repairs are often associated with chronic
post-operative pain. While this complication has been linked among others to mesh
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deterioration, details of the processes that lead this deterioration are still unknown.
Here, we aimed to bridge this gap by analyzing the chemical, physical and
structural alterations in hernia repair meshes exposed to oxidative stress in vitro.
We developed a methodology to characterize effect of oxidation stress on structure
and properties of polymeric hernia repair meshes. It was shown that structural
changes in polypropylene meshes exposed to oxidative stress may involve
formation of cross-links between the polymer chains, chain scissions, and
hydrogen bonds between the carboxyl groups, which are formed in the material
during the oxidation. These effects result in mesh stiffening, ultimately leading to
chronic post-operative pain. Moreover, we demonstrated that Composix™ meshes
are more vulnerable to the oxidative stress when compared with UltraPro®
meshes.
Consequently, we focused on coating polymeric hernia meshes with antiinflammatory agents in an attempt to mitigate the oxidative stress and improve
long-term outcomes of the surgery. In particular, polypropylene hernia repair
meshes coated with vitamin E (a-tocopherol), a known antioxidant, were prepared
and characterized. The adsorption isotherm of vitamin E on the mesh was
characterized and a release profile study yielded a promising results, showing
sustained release of the drug over a 10-day period. An animal study was
conducted, and histological analysis 5 weeks after implantation exhibited a
reduced host tissue response for a modified mesh as compared to a plain mesh,
as evidenced by a higher mature collagen to immature collagen ratio, as well as
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lower level of fatty infiltrates, neovascularization and fibrosis in the case of modified
mesh. These results support the use of a-tocopherol as a potential coating in
attempt to reduce the extent of post-operative inflammation, and thereby improve
long-term outcomes of hernioplasty.
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CHAPTER 1
INTRODUCTION
Nowadays, implantation of medical devices has become a conventional
treatment modality for numerous medical conditions. Implants are artificial
structures, which are placed inside or on the surface of the human body in an
attempt to replace a missing biological part, or to restore its original functions.
Currently, tens of millions of Americans have medical implants in their bodies.
Examples of implants are catheters, orthopaedic and cardiovascular devices,
neurological and contraceptive implants, etc. Despite being made of highly
biocompatible materials, surgical implants trigger the host response, which can
lead to implant-associated complications. Rejection, chronic inflammation,
hemorrhage, implant migration and failure, and tissue damage are among the most
common implant-associated complications [1,2]. However, the most impactful
complications are post-surgical infections and post-operative chronic pain, as they
result in the highest morbidity and mortality rates. These complications place a
significant burden on the healthcare system, as in many cases revision surgery is
the only treatment option for the patients. Therefore, developing approaches to
prevent and treat post-surgical complications appears to be an important research
direction.
The ultimate goal of the present study was to develop strategies to decrease
the burden of medical implant – associated complications, thus improving long-
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term surgical outcomes. A particular focus of this study was on two most significant
complications: implant-associated infections, and post-operative chronic pain.
In the first part of the dissertation (chapter 3) we address post-surgical
infections in the example of orthopaedic Kirchner wires (K-wires). Despite all
recent improvements in orthopaedic surgery techniques and post-operative care,
clinical infections continue to be one of the most serious complications, particularly
when external fixators, such as K-wires, are used. In fact, multiple evidence
suggests that the infection rate following K-wiring procedures is high and can reach
30 - 100% [3,4]. Therefore, the search for an optimal approach to mitigate pin-site
infections is an important objective.
In the second part of the dissertation (chapters 4, 5) we address postoperative chronic pain in the example of hernia repair meshes. Hernia repair is the
most common surgery in the US with over a million procedures performed
annually. Post-hernioplasty chronic pain is a major complication affecting 20 - 30%
of patients undergoing hernia repair. Therefore, development of the strategies to
prevent or reduce the extent of post-hernioplasty chronic pain is of particular
importance.
Current clinical strategies to reduce the burden of these complications rely
heavily on the systemic administration of various drugs (antibiotics or painrelievers), as well as appropriate wound care. However, these approaches are far
from being perfect. For instance, systemic drug administration often results in
adverse side effects. Additionally, appropriate wound care has limited efficiency
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and is often neglected by the patients when needed for a prolonged period of time.
Therefore, much research effort these days is focused on the development of novel
approaches to reduce the emergence of implant-associated complications.
Surface modification is among the most widely used and prominent strategies.
Coating medical implants with various therapeutic agents provides drug delivery
directly to the surgical site, improving outcomes of the operation. Moreover, since
systemic administration is avoided, drug doses can be reduced; therefore, this
approach promises a reduction of possible systemic side effects. However, in
certain cases implant surface modification can cause undesirable effects upon
implantation. For example, several therapeutic agents incorporated into
antimicrobial coatings were shown to lack biocompatibility and possess feasible
cytotoxicity, which can substantially impair the healing process [5]. Furthermore,
since many therapeutic agents are water-soluble, it is difficult to provide and
control sustained drug release in the vicinity of the implant. Therefore,
development and optimization of the modification protocols, as well as the search
for novel therapeutic agents appear to be critical objectives. In the present
dissertation, we proposed to use water-insoluble, naturally-derived compounds as
therapeutic agents to coat medical implants in an effort to improve long-term
outcomes of surgeries.
The first specific aim of the present study was to develop a novel
antimicrobial coating for orthopaedic implants, which combines pronounced
antibacterial activity against common pathogens along with minute cytotoxicity.
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Given that emergence of post-operative infections is particularly common for
external fixators, we focused on studying Kirschner wires (K-wires) - the most
widely used external fixators. In the first part of the study we proposed coating Kwires with monolaurin — natural compound found in coconut oil. Being widely used
in food and cosmetic industries, monolaurin was shown to exhibit excellent
antimicrobial

properties

against

various

microorganisms,

including

Staphylococcus aureus (both methicillin-resistant, MRSA, and methicillinsensitive, MSSA, species) and Staphylococcus epidermidis, which combined are
responsible for more than 80% of K-wire infections [6,7]. In spite of this fact, the
use of monolaurin in biomedical applications was somewhat limited. In the present
dissertation, K-wires were coated by monolaurin, followed by the detailed
physicochemical characterization of the coating and assessment of the
antimicrobial properties of the modified K-wires against Staphylococcus aureus
strains (both, MSSA and MRSA) and Staphylococcus epidermidis. Additionally,
cell culture experiments with mouse 7F2 osteoblasts were conducted to test
cytotoxicity of the coated wires.
In the second part of the dissertation we focused on post-surgical pain. As
stated above, post-operative chronic pain is a major complication, particularly
common for hernia repair surgeries. A consensus has not yet been reached on the
exact cause for this pain, however there are indications that oxidative stress, a
result of the body’s inflammatory response, may play a key role. For instance,
enhanced activity of inflammatory cells was shown to induce oxidative stress in the
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vicinity of the implant [8]. Moreover, physical and chemical integrity of hernia repair
mesh can also be compromised. In particular, experiments with explants
demonstrated that changes of mesh shape, as well as implant shrinkage can occur
after the surgery leading to severe discomfort [9]. However, there is still a lack of
understanding of the mechanism of hernia repair mesh deterioration in human
body.
Therefore, the second specific aim of the present dissertation was to study
the mechanism of oxidative deterioration of hernia repair meshes. Pursuing this
aim, we focused on simulating the effect of reactive oxygen species (ROS) and
hypochlorite anions on hernia repair meshes. We treated mesh samples in model
environments that contained either H2O2 (in the presence ofCoCl2 and glass wool),
or hypochlorite. The samples were then analyzed by means of several
physicochemical techniques, including FTIR, DSC, SEM, XPS. Tensile strength
testing was performed to evaluate mechanical properties of the analyzed meshes
before and after the treatments. Results of these studies were used to determine
the role of oxidative stress in the deterioration of hernia mesh in the body.
The third specific aim of this study was to develop anti-inflammatory coating
for hernia repair meshes in an attempt to mitigate oxidative stress and reduce the
incidence rate of post-hernioplasty chronic pain. In this part we hypothesized that
vitamin E-coated polypropylene mesh would promote reduced inflammatory
response around the implant, improve its mechanical durability, and decreased
connective tissue formation, resulting in a more robust hernia repair with better
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surgical outcomes. Utilizing a retromuscular approach to hernia repair, we
assessed the characteristics of vitamin E as an anti-inflammatory coating through
both in vivo and pilot in vitro studies.

Organization of the dissertation:
• Chapter two provides a comprehensive literature review that embodies the
following topics:
- Orthopaedic implants – associated infections and current strategies to
address this problem;
- Overview of hernia repair surgeries and post-hernioplasty complications;
- Current approaches to prevent and treat post-hernioplasty complications.
• Chapter three discusses the novel antibacterial coatings on orthopaedic
implants;
• Chapter four describes the in vitro study on polypropylene hernia repair mesh
deterioration;
• Chapter five focusses on the development of anti-inflammatory coating on
hernia repair meshes;
• Chapter six draws final conclusions and provides recommendations for further
studies.
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CHAPTER 2
LITERATURE REVIEW
2.1. Orthopaedic implant-associated infections
The potential for post-operative infection exists for all areas of medicine
involving the implantation of foreign objects. Orthopaedic implant-associated
infections (Fig. 2.1) are of particular importance as they result in high rates of
morbidity and mortality. [10–13]. The present chapter focuses on orthopaedic
infections, and the most common strategies to treat and prevent its emergence.

Fig. 2.1. Photograph of the superficial pin site infection*.

In terms of susceptibility to infections, orthopaedic implants can be divided
into two groups. The first group includes the implants used for major orthopaedic
surgeries, such as total hip, knee, and shoulder replacements. The infection rate
for these types of implants is relatively low: according to several reports, the
incidence rate of post-arthroplasty infections is 1-2% [14,15]. An average rate of
infections following these major orthopaedic surgeries was estimated below 5%
* Photograph is provided by Dr. Christopher Gross, Department of Orthopaedics,
Medical University of South Carolina, Charleston, SC, USA
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[10]. However, if an infection emerges, it resides in the bone tissues causing high
morbidity, and in some cases mortality. The second group is comprised of
temporary orthopaedic implants, such as screws, pins, plates, wires, etc. The
infection rate for those devices is considerably higher. For instance, the infection
rate following external fixator surgeries was shown to exceed 30% [3]. For longer
implant residence time and in the case of devastating traumas, the pin-site
infection rate was shown to reach 100% [4]. Fortunately, the emergence of
infections does not lead to the high morbidity and mortality, although revision
surgeries are required to eradicate the contaminants.
Upon implantation, foreign bodies get exposed to numerous plasma proteins
that absorb on implant surfaces in a matter of minutes. Although these proteins
are necessary to promote cell adhesion and wound healing, multiple pathogens
can also adhere and colonize on the protein-coated surfaces [16]. There are three
general mechanism of the emergence of orthopaedic infections: 1) bacterial
pathogens migrate from external sources; 2) bacteria are carried by blood from
other parts of the body; 3) recurrent infections [11]. The first mechanism is
particularly relevant for external fixator infections, as these implants provide an
accessible passage for external contaminants.
Following bacterial adhesion, pathogens proliferate rapidly and are capable
of secreting exopolysaccharides, thus, forming a biofilm—a robust structure that
shields microorganisms from the host inflammatory response, and systemically
administered antibiotics [11]. Therefore, if a biofilm is formed, treatment of an
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infection often becomes difficult and, in some cases, a revision surgery is required
[10].
Pathogens that cause orthopaedic implant-associated infections vary
between countries. In the US, more than 80% of those infections are caused by
methicillin-resistant and methicillin-sensitive S. aureus (MRSA and MSSA,
respectfully) and S. epidermidis (MRSE and MSSE, respectfully) [15]. In European
countries, considerable fraction of infections (ca. 90%) is associated with
Staphylococcus spp. In their turn, Enterococcus and Streptococcus spp. account
for approximately 8% of cases [17]. The infections caused by methicillin-resistant
species is of particular importance, since they require specific prophylaxes and
treatment modalities[11].
Management of musculoskeletal infections puts an additional economic
burden on the healthcare system. In fact, treatment of necrotizing fasciitis, a type
of infective complication associated with external fixations, was estimated in the
range of $20,000 - $866,000 per patient [18]. Parvizi et al. reported the cost of care
of periprosthetic joint infection to be ca. $68,000. Treatment of methicillin-resistant
infections was shown to further increase hospital charges [19]. The total economic
burden of orthopaedic infections is expected to reach $1.6B by 2020 in the US
[10].
If not treated properly, orthopaedic implant-associated infections may
substantially lower patient quality of life, and may even lead to mortality [20].
According to Bhattacharyya et al. a risk of infection-caused mortality after an
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orthopaedic surgery was estimated to be 1.62% [13]. However, for total hip
revisions for infections, a mortality rate of 26% within 2 years was reported [21].
Furthermore, osteomyelitis is claimed to be the leading cause of death in hand
surgery and sports medicine [13].
Therefore, prophylaxes and treatment of orthopaedic infections appear to be
of a paramount importance. Over the past years multiple strategies to manage
orthopaedic infections have been developed.

2.1.1. Clinical strategies to address orthopaedic infections
Current clinical strategies to prevent orthopaedic implant - associated
infections can be divided into three categories: preoperative, intraoperative, and
postoperative methods.
Preoperative methods rely heavily on patient skin disinfection using various
antimicrobial agents, such as iodine-based antiseptics, antiseptic soaps, and
chlorhexidine gluconate-based drugs [11]. The latter compounds were shown to
possess superb antibacterial activity, significantly reducing post-surgical infection
rates [22]. Moreover, other cutaneous preparations, including hair removal and
surgical draping, are conducted before surgery, and appear to be essential for
infection prophylaxes [11].
During the surgery, antibiotic prophylaxis is the major infection preventive
measure. In fact, it was shown that the absolute risk of infection is reduced by 8%
if antibiotics are administrated during the operation. Cefazolin, clindamycin and
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vancomycin are the most widely used antibiotics for this application [23]. Another
preventive measure involves the use of intraoperative lavage. Brown et al. showed
the significant decrease of the infection rate when dilute betadine lavage is used
during arthroplasty [24].
Postoperative prevention methods include antibiotics prophylaxis and
evacuation drains. According to the American Association of Orthopaedic
Surgeons (AAOS), antibiotic administration should remain during the first 24 hours
after a major orthopaedic surgery [11]. Although multiple reports show the efficacy
of evacuation drains in terms of infection prophylaxis, superficial bacteria can use
drain tubes as a passage to the injury site. Therefore, drain tracts are
recommended to be removed between 24h and 48h [25].
However, currently used clinical strategies lack efficiency due to several
factors. Among these is the development of drug resistance, inability to eradicate
all the microorganisms lodging in patient’s skin, and insufficient wound care.
These translate to the relatively high incidence rate of orthopaedic implant –
associated infections. Therefore, much research focuses on the development of
novel approaches to prevent orthopaedic infections.

2.1.2. Research strategies to fight orthopaedic infections
In the search for an optimal strategy to prevent and treat orthopaedic
infections, multiple approaches are currently being developed and tested. Most of
the studies published in this area can be divided into two categories: development

11

of an antibiotic-loaded bone cement, and modification of orthopaedic implants with
antibacterial agents.
Bone cement is a polymeric material that consists of poly(methyl
methacrylate) (PMMA) micro-beads cross-linked by PMMA chains. This material
is primarily used to secure joint-replacement implants [26]. Due to its relatively high
porosity, bone cement appears to be an excellent matrix for antimicrobial agents.
The ultimate aim of the antibiotic-loaded cement is to deliver antimicrobial drugs
directly to the implant surface and surrounding bone [12]. In 1979 Klemm et al.
demonstrated excellent antimicrobial properties of the gentamicin-loaded cement,
and since then, various antibiotics have been tested as additives to the bone
cement [26]. Scott et al. showed that tobramycin-loaded cement exhibited
pronounced antibacterial activity against the pathogens causing 98% of
orthopaedic infections [27]. Several studies demonstrated excellent activity of
vancomycin and amphotericin B impregnated into the cement [11,28].
Despite the success of in vitro, animal and clinical studies of antibioticimpregnated bone cements (AIBC), a number of scientists and physicians oppose
the use of these compounds in joint replacement surgeries [12]. Their major
concern is the alteration of mechanical properties of the cement when antibiotics
are loaded. Moreover, control and adjustment of the drug release kinetics from
AIBC is often difficult. Insufficient drug release can also contribute to the
development of antibiotic resistance. However, feasible progress has been made
in this area by optimizing cement composition [26].
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It is important to note that the use of AIBC is somewhat limited, as many
orthopaedic surgeries do not require cement for implant fixation. Therefore, the
use of AIBC cannot be considered as a universal approach to address the
incidence of orthopaedic infections.
Another research strategy to eliminate orthopaedic infections involves the
development of antimicrobial coatings on the implants. Various antibacterial
agents are either covalently grafted to the surface, or physically adsorbed, or
incorporated into polymeric matrices to achieve prolonged drug delivery [12].
Moreover, several studies focused on “hybrid antibacterial surfaces”, which
combine covalently attached antibiotics and controlled release systems [29,30].
Most research dealing with covalent modification of metallic implants
focuses on grafting vancomycin using various linkers, such as diphosphonic acid,
various silanes, glycidyl-containing groups, etc [12]. Besides vancomycin, several
other antibiotics, including daptomycin, kanamycin and tetracycline, were
successfully tethered to metallic surfaces [31,32]. Additionally, metallic surfaces
modified with silver nanoparticles have also been extensively tested [33]. Multiple
in vitro and animal studies showed feasible antibacterial activity of the modified
implants against orthopaedic device-related pathogens [33]. However, when
covalently grafted, antimicrobial agents often exhibit reduced antibacterial activity
due to the alterations of their chemical structure. Moreover, therapeutic
compounds that interact with bacterial DNA lose their activity completely when
grafted to the surface due to diffusion limitations. Furthermore, sustained drug
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release cannot be achieved when therapeutic compounds are covalently linked to
or immobilized on the surface of the implant. Another concern is associated with
high cytotoxicity of the surfaces modified with silver nanoparticles.
Several studies focused on physical adsorption of antibiotics and antiseptics
on orthopaedic implants. Surfaces modified with various conventional antimicrobial
agents (e.g. chlorohexidine, gentamycin, vancomycin, etc.) have been tested in
vitro and demonstrated prominent antibacterial properties. At the same time,
successful animal studies with physically adsorbed antibiotics were not reported in
the literature, potentially due to the insufficient mechanical stability of the coatings
[20,33]. Therefore, additional studies are required to establish if physically
adsorbed drugs can be used in orthopaedic applications.
Controlled drug delivery is a powerful treatment modality drawing the
attention of scientists in various areas of medicine. However, only few studies dealt
with drug eluting coatings on orthopaedic implants [34–36]. Low work of adhesion
between the metallic surface and polymeric matrix, which provides controlled drug
release, makes it difficult to adhere a drug-eluting layer to the implant.
Nevertheless, several studies focused on the modification of titanium and stainless
steel orthopaedic implants with polylactide and polyglycolide coatings loaded with
different antibiotics, such as gentamicin, triclosan and teicoplanin [36,37].
Preliminary in vitro and animal experiments demonstrated the pronounced
antibacterial activity of the modified implants against MSSA, MSSE and
P.aeruginosa. Other studies focused on the incorporation of antimicrobial agents
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into a hydroxyapatite layer. Coatings loaded with tobramycin, vancomycin,
amoxicillin, silver nanoparticles, etc. were tested against most of the orthopaedicrelated infections [38–40]. Animal studies suggested that ceramic coatings
impregnated with antibiotics can not only prevent orthopaedic infections, but also
significantly improve osseointegration.
Despite current achievements in the development of antimicrobial coatings
on

orthopaedic

implants,

this

approach

possesses

several

important

shortcomings. In particular, most antibiotics and antimicrobial agents (such as
silver nanoparticles) exhibit feasible cytotoxicity, which was shown to impair
fracture healing [41]. Moreover, modification of orthopaedic implants often requires
physical and/or chemical treatments, which can alter implant characteristic,
ultimately affecting osseointegration [42]. Therefore, the search for an optimal
strategy to prevent and treat orthopaedic infections is still ongoing.

2.2. Hernia repair
2.2.1. Historical aspects of hernia
The word hernia comes from Latin and means rupture of a portion of a
structure. One can define hernia as a bulging of an organ (or a portion) through an
abnormal hole or opening into an area where it should not be originally located.
Hernias have been drawing attention of physicians since the dawn of the surgical
era, primarily due to the high prevalence of this medical condition [43]. In 1892 Dr.
William Halsted, professor of surgery at John Hopkins University, claimed: “There
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is perhaps no operation which has had so much of vital interest to both physician
and surgeon as herniotomy, and there is no operation which, by the profession as
large, would be more appreciated than a perfectly safe and sure cure for rupture”
[44]. This statement demonstrates the profound impact of hernia formation and
hernia repair surgeries.
According to Lyons et al. hernias were first mentioned in the Egyptian
Papyrus of Ebers at ca. 1552 BC, where ancient physicians characterized this
condition as an abdomen swelling caused by coughing or other physical activities
[45]. The next significant reference to hernias was made in the book “On the
Surgery” written by Hippocrates in 352 BC, where he speculated about the
susceptibility of young children to hernias [46]. Hippocrates followers, who are
claimed to be the founders of anatomy and physiology, were shown to practice
hernia repair among other surgeries.
Aulus Cornelius Celsus, one of the most ardent followers of Hippocrates,
brought his knowledge to the Roman Empire, where he did much to advance the
techniques [47]. Celsus provided the first detailed descriptions of hernia defects,
hernia repair techniques, and records of the operations conducted in “Alexandrian
traditions”. State-of-the-art procedures introduced by Celsus were further
developed by Heliodorus and Gallen of Pergamum. The most advanced technique
involved litigation of the hernia sac, followed by the amputation of the testicles, in
the case of groin hernias [48].
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Unfortunately, the major improvements to hernia repair of hernia repair
surgeries were lost and forgotten during the middle ages. Not until the 13th century
a novel herniotomy technique was described and successfully implemented [43].
William of Salicet, a talented surgeon from the medical school of Salerno, modified
Celsus’s approach and managed to both close the hernia sac and preserve the
testicles.
The next significant development of hernia repair was made by Ambroise
Pare in the16th century; he proposed for the first time to separate the peritoneum,
and use it to close the hernia defect [49]. If the proposed technique was not
possible, Pare suggested to use the Golden Ligature to close the opening. Pierre
Franco introduced further improvements to the Pare’s technique completely
eliminating the necessity to excise testicles and spermatic cord in the case of groin
hernias. Kaspar Stromayr, in his turn, was the first surgeon to describe the
differences between direct and indirect hernias. Moreover, he developed multiple
surgical approaches for both types of hernias [47].
Hernia research in the 18th century was primarily focused on the study of its
pathogenesis. Drs. Cooper and Richter conducted the most advanced research of
their time, and were the first to recognize the role of transversalis fascia in the
development of hernias [43].
Despite the number of herniotomy techniques developed by the beginning
of the 19th century, none of them was flawless leading to a high incidence of failures
and recurrences [45]. An Italian surgeon, Eduardo Bassini, addressed these issues
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by introducing a pioneering technique called the Bassini repair [50]. This approach
involved sewing the hernia defect followed by reconstruction of the abdominal
floor. This was done by approximating the conjoined tendon to the inguinal
ligament. The Basini repair revolutionized hernia repair surgeries resulting in a
substantially lower complication rate [50]. Up until the late 1950s, the Basini repair
appeared to be a gold standard for hernia repair surgeries. Nonetheless, several
surgeons further developed the approach improving the efficacy of the
methodology. For instance, Harvey Cushing pioneered the use of local anesthesia
while performing the Basini repair [51].
Although several essential modifications to the original Basini repair
technique were developed and successfully implemented, the rate of post-surgical
complications was still relatively high [47]. Post-operative chronic pain and hernia
recurrence was among the most devastating complications. This was perhaps due
to the additional stress that was put on the adjacent tissues when the edges of the
defect were stitched together. It is important to emphasize that despite all the
advancements introduced by that time, the general concept of hernia repair
remained the same since the middle ages.
In the late 1950s the development of novel anesthetics gave rise to two major
hernia repair techniques: the tension-free hernioplasty and the Canadian
Shouldice repair [47]. These two novel approaches revolutionized hernia repair
surgeries resulting in more efficient and safe operations. This was done by
reconstructing the hernia defect and abdominal cavity by means of surgical mesh.
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In 1959 Dr. Usher and his colloquies conducted the first hernia repair surgery
involving polyethylene (Marlex) mesh being used for an additional reinforcement
of the ligation of the hernia sac [52]. Later that year, Usher proposed the use of
polypropylene mesh for closing hernia defects for patients with large protrusions
[53]. The choice of polypropylene mesh was dictated by: 1) the ability of
polypropylene to resist infections; 2) low immunogenicity; 3) mechanical
characteristics of the material. Outcomes of the surgery were remarkable; Usher
later stated: “The postoperative course of these patients has been remarkable.
They are quite free of postoperative pain, catheterization is seldom necessary and
they are able to walk in an erect position without discomfort’’ [53]. Another
important innovation of the Usher’s technique was the retention of a normal shape,
position and direction of the spermatic cord, in contrary to what was observed in
herniorrhaphies. By the beginning of the 1980s, Usher’s approach was
successfully optimized for all types of hernia defects, and since then the prosthetic
tension-free repair has been dominant in hernia repair surgeries [54]. However, it
is important to note that herniorrhaphies are still performed when operating infants,
repairing small and minor hernias, and in some developing countries, where there
is a lack of prosthetic meshes [55].
The emergence of laparoscopic surgeries positively affected hernioplasty
and resulted in a safer hernia repair. Filipi et al. reported the substantial
advantages of laparoscopic hernia repair over conventional hernioplasty [56]. The
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recovery time and long-term outcomes of the repair were shown to significantly
improve with the laparoscopic approach.

2.2.2. Biological aspects of hernia formation
Prior to discussing hernioplasty-related complications, it is important to
reveal and understand the processes preceding and causing the initial formation
of hernia. As mentioned earlier, hernia appears to be a defect in the form of a
weakening or a hole in a muscle wall, through which an organ or its part protrudes
to an area where it should not be originally located. Depending on the location of
the defect, physicians distinguish several types of hernia, including femoral,
inguinal, spigelian, umbilical, ventral, hiatus (Fig. 2.2).

Fig. 2.2. Types of hernia defects [57].
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Moreover, there are also incisional hernias, which emerge in the areas where
an incision or trauma previously occurred. Although there is no general consensus
regarding the mechanism of hernia development, many scientists believe that a
hernia is a disease of an extracellular matrix (ECM) [58,59]. Despite technological
advancements and developments in hernia repair surgeries, several reports
suggest that the decrease in hernia recurrence rate following the repair is marginal
[60].
Thus, it was proposed that the external factors (endogenous and
exogenous) may have more influence on the healing process than the surgical
procedure (Fig. 2.3) [61].

Fig. 2.3. The mechanism of hernia formation [59].

These factors were shown to affect collagen turnover in hernia patients [62].
There is a growing body of evidence suggesting that deviations in collagen
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production and metabolism contribute to both the initial formation of hernia defect
and the opening recurrence [58,62,63]. If collagen structure and integrity is
compromised, the process of tissue remodeling and wound healing is affected,
ultimately resulting in the deterioration of the ECM mechanical properties. This
claim was confirmed in papers studying tissue samples taken from the hernia
patients [58,62,64,65]. In the case of direct inguinal hernias, the rectus sheet was
shown to contain irregular collagen fibrils, making the tissue more compliant and
compromising biomechanical properties [66]. These observations were also
confirmed for incisional and recurrent hernias [67].
Another abnormality found in the analyzed tissue samples was the
decreased ratio of collagens type I/III in the fascia [59]. Moreover, in the case of
incisional hernias, significant alterations in the morphology of collagen fibers were
observed in the samples taken from the hernia sac, and newly formed tissues in
the vicinity of the defect [68]. These results are indicative of the compromised
metabolism of collagen.
Although the factors causing alterations in collagen metabolism are still a
subject of debates, there is a theory that overexpression or underexpression of the
matrix metallo-proteinases (MMPs) play a role in collagen deterioration [59]. MMPs
are a class of enzymes capable of degrading components of ECM, specifically
collagen. MMPs play an important role in tissue remodeling and wound healing
processes. With regard to hernia formation, Bellon et al. demonstrated an
increased concentration of MMP-2 in the tissue samples taken from the patients
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with inguinal hernia [69]. Other studies showed overexpression of MMP-1 and
MMP-13 in fibroblasts in the case of recurrent inguinal hernias [70,71]. Antoniou
et al. confirmed previous observations showing high levels of MMP-9 and MMP-2
in the patients with inguinal hernias [72]. At the same time, concentrations of
MMP’s inhibitors, TIMP metallopeptidase inhibitor (TIMP), was found to be
significantly lower when compared to the healthy patients [58,72]. Therefore, MMP
and TIMP may play an important role in the development of hernia defects.
However, there are other factors leading to hernia development.
In the case of incisional and recurrent hernias, alterations in the architecture
of a newly-formed tissue was shown to play a significant role in the development
of an opening [73]. Type I and type III collagen are major components of scar
tissue. Collagen type I is composed of highly-organized fibrils, aligned towards the
stress lines, and possesses robust biomechanical properties. Type III collagen is
significantly softer and more compliant when compared with the type I [59]. It
consists of thin tropocollagen fibrils secreted by fibroblasts during the remodeling
phase of the wound healing [74]. Type III collagen is often called “immature”, and
after being produced, it is then transformed into type I (“mature”) collagen at a later
stage of wound healing [75]. Thus, the decrease of type I/III collagen ratio can
cause deterioration of the ECM biomechanical properties, ultimately resulting in
the formation of a hernia defect [68].
Klinge et al. confirmed this theory, demonstrating a significant increase in
type III collagen content in hernia patients [76]. Another study showed an
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increased level of type III collagen production in patients with pronounced
herniation [77]. These observations were additionally confirmed in the literature
[68,71,78]. Animal studies reviewed by Deeken e. al. showed a significant drop of
the ECM biomechanical strength, as well as high content of collagen type III [79].
There are several factors causing alterations in type I/III collagen ratio.
Several studies suggested that modified expression of various collagenase, in
particular MMP-2 and MMP-13, is a key reason for the high type III collagen
content in hernia patients [71,80,81]. At the same time, Ajabnoor et al. showed
little to no difference in the activity of various MMPs in hernia and control patients
[54]. Therefore, the predominance of type III collagen in the hernia group can be
ascribed to the alterations of collagen expression.
Genetic factors can also be responsible to the overproduction of collagen
type III in hernia patients. Jansen et al. showed that impaired regulation of the
collagen gene can result in significant alterations during injury-related wound
healing [82]. In particular, the transition of collagen type III to type I can be severely
compromised.
With regard to recurrent hernias, several studies showed that herniation can
be caused by post-operative chronic inflammation, ultimately causing impaired
mesh tissue integration [58,83]. Although mesh materials are believed to be highly
inert, in ca. 20% of cases post-hernioplasty inflammation does not resolve,
accelerating macrophage and neutrophil recruitment to the injury [54]. These nonlymphatic white blood cells produce a myriad of oxidants and enzymes, which were
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shown to affect the fibrillogenesis [54,58]. As such, type I/III collagen ratio may be
significantly lower in inflammatory conditions when compared to the resolved
inflammation (Fig 2.3).
Exogenous factors can also play a role in the development of herniation.
Lifestyle diseases, in particular diabetes, obesity, smoking, and drug abuse, were
shown to substantially affect fibrillogenesis, causing a decrease of the type I/III
collagen ratio and, thus, increasing the chance of hernia formation [54].

2.2.3. Overview of hernia repair meshes
As stated previously, prosthetic hernioplasty is currently a gold standard for
surgical hernia repair. These operations imply the use of surgical mesh for tissue
reinforcement. Over the past decades, a variety of different hernia meshes have
been developed.
Initial development of hernia meshes aimed to create an implant capable of
withholding intra-abdominal pressure and providing tissue ingrowth. These
requirements dictated the shape and structure of hernia meshes, and resulted in
the development of implants with thick polymeric filaments. These meshes are
called heavy-weight due to the high density and amount of the polymer used in
production. However, multiple evidence showed that the host-tissue response
provoked by heavyweight meshes was relatively high, resulting in impaired healing
[64,84,85]. As discussed previously, excessive inflammatory response following
hernioplasty can result in post-hernioplasty complications. Moreover, movement
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constraints and increased chances of hernia recurrence were also recorded for
patients with heavyweight meshes [83,86].
After the value of intra-abdominal pressure was determined, it became clear
that the amount of polymer composing the meshes could be substantially
decreased [75]. In 1998, a Vypro® mesh was introduced and became the first
lightweight hernia repair mesh. This type of implant consists of thin polymeric fibers
and large pores that facilitate tissue ingrowth. Implantation of the lightweight
meshes was shown to reduce host-tissue response when compared with the
heavyweight meshes [55,79]. Moreover, lightweight hernia repair meshes are
significantly more compliant, and do not generally shrink after implantation [87].
These characteristics were shown to substantially improve the outcomes of
hernioplasty as well as patients’ quality of life after the surgery. However, multiple
reports suggest that implantation of the light-weight meshes can still lead to posthernioplasty complications, including recurrences, chronic pain, infections, etc.
[75,85]. Therefore, minimizing mesh density is not sufficient to eliminate the burden
of post-hernioplasty complications.
Lake et al. used a porcine model to study the influence of pore size and
shape on tissue integration and wound healing following hernioplasty [85]. Meshes
with square, diamond and hexagonal pores were implanted, and the T-peel test
was used thereafter to quantify mesh tissue ingrowth. Meshes with hexagonal
pores were shown to possess the most pronounced tissue integrative properties,
followed by diamond-like and square pores. With regard to the pore size, it was
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shown that meshes with medium pores (3.8X3.9mm) exhibited the best tissue
integration and ingrowth when compared to the large (4.9X5.1mm) and small
(1.7X3.6mm) pores. However, previous reports suggested that implantation of the
meshes with ultra-large diamond-like pores led to the best outcomes in terms of
tissue integration and compliance, as well as post-operative chronic pain [88,89].
Large-pore meshes were also shown to reduce foreign body sensation [88].
Therefore, the ideal pore shape and size is still subject of a debate, however, most
studies suggest that small pore hernia meshes provoke significant host-tissue
response, culminating in impaired healing.
Over the past decades, many researchers have been involved in a search
for an ideal material for hernia repair implants. All meshes developed currently can
be divided into three categories: non-absorbable, absorbable, and biological.
The following polymers are commonly used to produce non-absorbable
meshes: polypropylene (PP), polyester, polytetrafluoroethylene (PTFE, Teflon),
and polyvinylidene fluoride (PVDF). According to multiple reports, PP meshes are
the most widely-used, primarily due to the favorable mechanical properties; these
meshes also provide sufficient tissue ingrowth and incorporation [90–92].
Moreover, PP meshes are inexpensive and available in most institutions. At the
same time, several studies suggest that PP meshes lose compliance upon
exposure to oxidative stress [93,94].
Polyester meshes are also widely used in several European countries.
These meshes provide excellent tissue integration and are less susceptible to the
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foreign body reaction when compared with PP meshes [95]. At the same time,
polyester meshes were shown to be more susceptible to infections, as well as
losing their integrity and strength over time due to the material degradation [96,97].
Moreover, excessive tissue deposition and adhesions were shown to be an issue
[97].
PTFE hernia repair meshes became widely used after the release of the
Gore-Tex® Soft Tissue Patch. These meshes gained success due to their
chemical and biological inertness, which significantly reduces tissue adhesions
and foreign body reaction [98]. On the other hand, several studies suggest that
PTFE meshes exhibit low tissue ingrowth and high recurrence rate due to having
poor mechanical properties [99,100]. Moreover, implantation of the PTFE meshes
is often associated with higher infection risks [101].
Although PVDF meshes are relatively new on the market, multiple clinical
studies suggest that they possess excellent tissue integrative properties, sufficient
mechanical properties, and do not provoke tissue adhesions [8,102]. Moreover,
the risk of infections is low when compared with PP and polyester meshes [103].
Host-tissue response was also shown to be mild, and comparable with that of
PTFE meshes [103]. However, another meta-analysis showed a high recurrence
rate associated with the PVDF meshes [104]. Therefore, further studies are
required to establish clinical outcomes of the PVDF hernia meshes.
Most of the absorbable meshes are made of polyglycolic acid or polylactic
acid. The first absorbable meshes were introduced in 1983 and were expected to
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become a golden standard for hernia repair. However, it was later shown that these
implants provoked pronounced host-tissue response leading to an impaired
healing and increased chances of recurrence [54]. Therefore, modern absorbable
meshes are used infrequently, and are substituted with composite meshes, such
as UltraPro® mesh system that consists of polypropylene and poliglecaprone-25
fibers [100]. This type of implant combines the advantages of both absorbable and
non-absorbable meshes. Composite meshes are widely used nowadays, and were
shown to provide excellent tissue-integration [100]. The mechanical properties of
these meshes are sufficient to avoid hernia recurrence. However, due to the
degradation of the absorbable portion, composite meshes were shown to provoke
mild to low host-tissue response [54]. Therefore, none of the polymeric meshes is
without disadvantages.
Development of the approaches to obtain biological tissue grafts led to the
emergence of bioprosthetic meshes, which are mainly composed of extracellular
matrix (ECM). These implants were claimed to possess paramount tissueintegrative properties, match the mechanical properties of their predecessors, and
resist contaminations [105]. The last quality—the ability to be used in infected or
potentially infected areas—appeared to be a genuine breakthrough and was highly
promoted in the literature [54].
Surprisingly, the performance of biological meshes was found to be below
expectations. Cano et al. provided a comprehensive comparison of the clinical
experience with biological and prosthetic hernia repair meshes [106]. Although
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there are data suggesting that ECM - derived meshes are effective, there is still no
consensus of how or when to use biological implants. Moreover, there is no longterm data showing long-term effects of biological meshes. Having analyzed clinical
evidence, Cano et al. concluded that biological implants should be used only when
the use of synthetic implants may be harmful. For instance, biological meshes were
recommended for immunocompromised patients, in the case of contaminated
surgeries, or for the patients with chronic infections without large bacterial inocula.
It is important to note that the use of biological meshes is contraindicated in
infected patients with large bacterial inocula. These results are in good correlation
with those published by Bellows et al. [105]. They reported a lack of high-quality
clinical evidence of the superiority of bioprosthetic hernia repair meshes over
polymeric implants. Thus, the use of the ECM-based meshes in hernioplasty
should be performed with caution. Le et al. performed a review on the use of
different kinds of hernia repair meshes including conventional and bioprosthetic
implants [107]. It was shown that the use of biological meshes is preferred in the
high-risk clean cases such as morbid obesity, smoking, immune suppression and
history of previous infections. Surgeons should strongly consider ECM-based
implants in patients with an increased number of comorbidities or risk factors.
Smart et al. showed that, despite the lack of clinical data for biological hernia repair
meshes, the use of three implants, AlloDerm™, Permacol™ and Surgisis™,
drastically decreased hernia recurrence rate [108].
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Therefore, despite the quantity and diversity of hernia repair meshes on the
modern market, none is flawless, resulting in complications following hernia repair.
At the same time, it is important to note that polypropylene meshes continue to be
a gold standard for hernioplasty.

2.2.4. Complications following hernioplasty
Although hernia repair meshes used nowadays are claimed to be safe,
biologically inert and biocompatible, clinical practice shows that mesh implantation
can initiate several undesirable processes (e.g. fibrosis, excessive inflammation,
calcification, etc.), which lead to post-hernioplasty complications [109]. This
chapter focusses on the most common complications following hernia repair
surgeries.
Every hernia repair is followed by a host-body response [54]. This process
involves migration of non-lymphatic white blood cells, particularly monocytes and
neutrophils, and their subsequent activation. Once activated, macrophages and
neutrophils release a myriad of oxidants (reactive oxygen and reactive nitrogen
species) and enzymes that interact with both the implanted material and
surrounding tissues [93]. This leads to the development of granuloma that can
cause seroma formation, tissue adhesions, mesh migration, as well as chronic pain
[75].
The risk of seroma formation is feasible only in the case of large and
complicated incisional hernias [110]. The risk increases concurrently with
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dissection extent. Seroma rates are generally higher for Teflon® meshes (5-15%)
as compared with polypropylene implants (5-8%) [111,112]. Although in some
cases seroma can resolve spontaneously, drains or catheters are often required
to treat the complication [110].
A cascade of various cellular and humoral effects following hernia repair
surgery can cause the formation of peritoneal adhesions (Fig. 2.4) [113]. This often
results in chronic pain and movement constraints [54]. Once these symptoms are
observed, and the adhesions are confirmed, a revision surgery is required. The
rate of adhesions following hernioplasty was shown to be ca. 3.3% [114].

Fig. 2.4. Photograph of explanted hernia meshes showing tissue adhesions and mesh
shrinkage [117].

There are several strategies to reduce adhesiogenesis. In particular, little to
no tissue adhesions were observed after implantation of biological meshes and
those made of Teflon [75,115]. Another strategy involves coating polymeric
meshes with collagen, which was shown to significantly enhance tissue integration
and eliminate adhesiogenesis [116].
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While performing hernioplasty, surgeons typically use sutures to fixate the
mesh. However, several studies showed that in ca. 1% of cases, hernia meshes
can migrate due to an improper fixation or external displacing forces [118,119,
109,120]. Mesh displacement can also occur due to the trans-abdominal forces.
Mesh migration was shown to trigger the inflammatory process, leading to chronic
pain [54].
Along with post-operative chronic pain, mesh-related infections are the most
devastating complications of hernioplasty. Many meta-analyses focusing on the
prevalence of hernioplasty associated infections have been conducted over the
past years [109]. An infection rate of up to 8% was reported in the literature [121].
For patients suffering from obesity and diabetes the rate was shown to be even
higher [1].
Leber et al. studied the influence of surgical techniques on the infection
incidence rate [122]. Interestingly, it was shown that there is no direct correlation
between the surgical approach used for hernioplasty and the infection rate.
Although, there is a general opinion that laparoscopic approach reduces postoperative complications, there is no data supporting this notion with regard to posthernioplasty infections [1].
Several studies focused on the correlation between the mesh type and the
infection incidence rate [122,123]. A significant increase in infection rate was
shown when microporous meshes (e.g. Teflon meshes) are used. These implants
possess pores with a diameter of ca. 10 μm, which enables bacteria to lodge on
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them and form a biofilm [1]. At the same time, non-lymphatic white blood cells are
too large to penetrate the pores, resulting in inability to provide sufficient immune
response.
With regard to the pathogens causing post-hernioplasty infections,
Staphylococcal species were reported to be responsible for most of the cases.
Moreover, the incidence rate of methicillin-resistant Staphylococcus aureus
(MRSA) infections following hernia repair was shown to reach up to 63% [124]. In
rare cases, post-hernioplasty infections are caused by Streptococcal species,
Enterobacteriaceae and Peptostreptococcus species [125].

2.2.5 Strategies to reduce post-hernioplasty complications
Despite being considered relatively safe and reliable procedure, hernioplasty
is often associated with post-operative complications. As previously discussed,
infections and chronic pain are among the most devastating complications
following hernioplasty. Despite all recent improvements to mesh design and
surgical procedures, complication rate is still approximately 25% [54]. Therefore,
development of strategies to decrease the burden of post-hernioplasty
complications is an important objective.
In an attempt to decrease the complication rate, several strategies focusing
on modification of hernia meshes with various coatings have been developed over
the past years. In particular, multiple studies focused on providing antibacterial
activity to hernia meshes by coating the latter with antiseptic or antimicrobial

34

agents [116]. A variety of conventional antibiotics (e.g. vancomycin, gentamicin,
rifampicin, etc.) and antiseptics (e.g. chlorohexidine, triclosan, etc.) have been
extensively tested to modify commercially available meshes [78,126,127]. In vitro
and in vivo experiments showed excellent results suggesting that antibacterial
coatings can significantly reduce the burden of post-hernioplasty infections.
However, several studies revealed that certain antibiotic and antiseptic coatings
exhibit potential cytotoxicity, which can result in adverse side effects and impair
healing [128,129]. Nonetheless, several antimicrobial coatings were shown to
possess low cytotoxicity along with the pronounced antibacterial activity [116].
Some of the products successfully underwent clinical studies and were approved
by the FDA. GORE became the first company to commercialize antibiotic loaded
hernia repair meshes (MycroMesh™ Plus).
Several strategies were used to incorporate antimicrobial agents into the
meshes. Dip-coating, electrospraying, and air brush spray techniques are among
the most widely used approaches to modify hernia meshes with antimicrobials
[78,130,131]. In particular, Yurko et al. demonstrated prominent antibacterial
activity of the lysozyme-coated hernia meshes against S. aureus [131]. Moreover,
multiple studies focused on drug incorporation into absorbable polymeric matrixes,
including those based on polylactide and polyglycolide (PLA and PLGA,
respectfully) [78,132]. These drug-loaded systems were then used to modify hernia
meshes in order to achieve prolonged drug release. Besides polymeric-based
systems, drugs were also incorporated into various hydrogels, including those
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based on chitosan [132]. These drug delivery systems were shown to provide
sustained drug release, enhancing the efficacy and reducing side effects of the
antimicrobial therapy.
Besides coating with antimicrobial agents, multiple studies focused on
modifying hernia mesh with anti-inflammatory drugs in an attempt to reduce foreign
body reaction. As discussed previously, excessive inflammatory response
following hernioplasty can cause various complications, in particular chronic pain
[54]. Reduction of the foreign body response can be achieved by implanting
biologically inert hernia meshes, such as those made of Teflon® or PET, as well
as biological meshes [75,109]. However, multiple reports suggest that even those
types of hernia meshes can trigger mild inflammatory response, resulting in an
impaired healing and chronic pain [116]. Therefore, several approaches have been
taken to modify hernia meshes with anti-inflammatory drugs. Many therapeutic
compounds, including ibuprofen, cortisone, tetracycline, have been incorporated
into hernia meshes [133,134]. In vitro and in vivo experiments revealed that
modified meshes provoked significantly lower foreign body reaction, improved
wound healing and resulted in a better architecture of a newly formed tissue.
Moreover, reduced granuloma formation and increased neovascularization were
also achieved by delivering anti-inflammatory drugs to the surgical site. Another
work demonstrated that foreign body response can be mitigated if compastin, a C3
complement system inhibitor, is integrated into the PP hernia meshes [135].
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Of particular interest is the C-QUR™ mesh developed and introduced to the
market by Atrium Medical. This implant appears to be a polypropylene mesh
coated with Omega 3 fatty acid gel, a well-known anti-inflammatory agent.
Preliminary animal and clinical studies demonstrated excellent anti-inflammatory
activity of the C-QUR™ meshes, which often resulted in an improved healing
following hernioplasty [100,136]. This led to the FDA approval of the C-QUR™
meshes in March 2006. However, it was subsequently shown that these meshes
are significantly more susceptible to post-surgical infections. Moreover, Kong et al.
reported that Omega 3 fatty acid coating on the C-QUR™ mesh can provoke a
pronounced host-body response [137]. Furthermore, handling characteristics of
these meshes were found to be poor due to the coating stickiness, which often
resulted in the mesh adherence to the package or gloves of the surgeons (Fig.
2.5). Therefore, C-QUR™ meshes are not currently widely used for hernia repair.
Moreover, as of 2016, there were 16 lawsuits filed against Atrium medical with
regard to the C-QUR™ meshes.

Fig. 2.5. Photograph of the C-QUR™ mesh adhered to the package [138].
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Another strategy to reduce the extent of foreign body reaction involves
camouflaging polymeric meshes with collagen-base hydrogels to avoid
immunodetection. Wolf et al. used a rodent model to demonstrate that ECM
hydrogel coating on PP meshes can significantly attenuate foreign body response
by reducing the activity of M1 macrophages and promoting M2 macrophages [139].
Thus, the healing process following implantation was significantly improved. The
results of this work are in a good agreement with other studies of collagen-based
coatings on polymeric meshes [140,141].
Several studies demonstrated that the inflammatory response towards
surgical meshes can also be reduced by promoting protein adsorption and
enhancing cytocompatibility of ultra-hydrophobic meshes [116]. Chen et al.
conducted animal studies showing that plasma treated PTFE meshes provide
significant increase in tissue integration when compared with the untreated
meshes [142]. At the same time, only minor encapsulation and granuloma
formation was observed for the modified meshes. Another study dealt with dualside PTFE meshes: one side was treated with plasma to increase the hydrophilicity
and promote tissue ingrowth, whereas the opposite one remained intact to avoid
tissue adhesions [143]. In vitro experiments confirmed the efficacy of that
approach; however, results of the animal studies were inconclusive.
Several studies dealt with hernia meshes modified with biological coatings
to enhance tissue integration. In particular, Gerullis et al. treated commercially
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available PP meshes in human plasma and demonstrated significant increase in
biocompatibility of the modified meshes [144]. Another study focused on the
chitosan-coated hernia meshes and demonstrated enhanced myofibroblast
adhesion and skeletal muscle ingrowth [145]. Moreover, chitosan coating
promoted the activity of M2 macrophages. Champault et al. conducted clinical
study of the meshes coated with beta-glucan [146]. Reduced recurrence rate was
reported for the coated implants. Moreover, post-operative chronic pain was also
reduced when the modified meshes were used.
As shown above, enhancing cell adhesion and tissue integration appears to
be an important objective. However, excessive tissue integration can result in an
undesired visceral adhesion, which ultimately leads to a chronic pain and
movement constrictions [54]. Several strategies to reduce and eliminate tissue
adhesions have been developed over the past years [116]. For instance, polymeric
meshes were combined with anti-adhesive layers in order to separate hernia mesh
and viscera. These layers are often made of ultra-hydrophilic polymers (e.g.
polyvinyl alcohol, polyethylene glycol, etc.) or hydrogels (e.g. gelatin, chitosan,
etc.) [147–149]. Ultra-hydrophobic materials were also used to create a barrier and
eliminate adhesions [150]. In 1996, Seprafilm® adhesion barrier was introduced,
and has since become one of the best option to avoid mesh-related adhesions
[116]. This layer consists of carboxymethyl cellulose cross-linked to sodium
hualuronate. During the operation Seprafilm® barrier is placed around the viscera
to avoid mesh contacting the organs. The adhesion barrier is then resorbed within
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7 days after the surgery. Multiple clinical data confirmed the high efficacy of this
approach [151]. However, there are several drawbacks of the Seprafilm® adhesion
barrier, in particular its high cost and adverse side effects [152].
Another approach to reduce tissue adhesions involves incorporation of antiadhesive therapeutic agents into hernia meshes [116]. Several animal studies
were conducted with polymeric meshes coated with sirolimus and taxomifen
[153,154]. The results suggested that modified meshes reduced visceral
adhesions, however, additional animal and clinical studies are required to evaluate
the efficacy of this approach.
A large body of research has been dedicated to hernia meshes in an attempt
to prevent and treat post-operative complications. However, the translation of
these studies into clinical practice is limited for a myriad of reasons. The present
study aims to develop novel approaches to reduce the incidence rate of postsurgical complications, improving long-term outcomes of prosthetic hernioplasty.
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CHAPTER 3*
TOWARDS ELIMINATION OF ORTHOPAEDIC INFECTIONS: NOVEL
ANTIBACTERIAL COATING ON ORTHOPAEDIC WIRES
3.1. Introduction
Kirschner wires (K-wires) are extensively used in orthopaedic applications
ranging from fracture fixation to deformity correction. Despite being very versatile
and fairly effective, the K-wiring procedure is often associated with common pintract infections that can lead to even more serious issues such as osteomyelitis
[155,156]. These infections arise from the use of percutaneous pinning techniques,
as seen in skeletal traction, percutaneous fracture pinning, and external fixation
for fracture stabilization or complex deformity reconstruction. Pin sites are niduses
for infections since the skin barrier is disrupted, providing a potential passage for
opportunistic bacteria to enter a previously privileged area. Multiple evidence
suggests that the infection rate following a K-wiring procedure ranges from 11 to
100 %, depending on the lifetime of the implant [3,4,157]. If appropriate pin care is
neglected, these infections can cause sepsis, osteomyelitis and sometimes
mortality [3,158]. The economic burden of treatment for this this type of infections
is expected to reach as high as $1.6B annually by 2020 [159]. Therefore, surgeons,
microbiologists, and material scientists alike are scrambling to find the best
possible solutions to this challenging issue.
* Results and data provided in this chapter were previously published in:
D. Gil, S. Shuvaev, A. Frank-Kamenetskii, V. Reukov, C. Gross, A. Vertegel. Novel Antibacterial
Coating on Orthopedic Wires To Eliminate Pin Tract Infections. Antimicrobial Agents and
Chemotherapy, 2017, 61(7), e00442-17, DOI:10.1128/AAC.00442-17
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In attempts to prevent pin track sepsis, multiple strategies have been
developed. Most of them involve coating the implants with antibiotics, antimicrobial
or anti-adhesion polymers and peptides; silver or nitric ions; nanoparticles; and
other antiseptics like chlorhexidine and silver-sulfadiazine [160–164]. However, a
major concern associated with the implementation of antibacterial coatings is their
adverse effect on adjacent tissues and bones, which inhibits fracture or fusion
healing [165]. Another important issue is the in vivo loss of antibacterial activity
resulting from the exposure of bacteria to sub-lethal concentrations of the drug,
eventually leading to development of drug resistance in situ [166]. Hence, the
development of novel coatings for reducing pin-site infections is of particular
importance.
Antibacterial properties of fatty acids and their esters have been extensively
studied over the past few decades. Monolaurin, also known as glycerol
monolaurate, was found to be the most effective antibacterial agent among these
compounds [167]. Monolaurin is currently used as a broad range antimicrobial
agent in food and cosmetic industries. Multiple studies have shown that besides
antibacterial properties monolaurin also possesses antiviral and antifungal activity
[168–170]. In an in vitro studies, monolaurin prevented biofilm formation of various
Staphylococcus species including Staphylococcus aureus (S. aureus) and
Staphylococcus epidermidis (S. epidermidis), pathogens that cause approximately
80% of orthopaedic implant-associated infections [18,19, 20]. It was also shown
that at sub-lethal concentrations, bacteria did not develop resistance to monolaurin
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[172]. In vivo experiments demonstrated that oral administration of monolaurin
appeared to be an effective approach to manage and treat S. aureus infections
[171]. In a surgical site infection model [7], monolaurin exhibited antibacterial and
antibiofilm activity against both gram-positive and gram-negative bacteria.
Therefore, a large body of evidence suggests that monolaurin possesses profound
antimicrobial properties, which make it an excellent candidate for antibacterial
coating on orthopaedic devices, in particular K-wires and external fixation devices,
because of high incidence rates of infections for these devices. Advantages of
monolaurin as a coating include its low cost, ease of application and “Generally
Recognized as Safe” (GRAS) status by the FDA; in addition, monolaurin’s low
water solubility may provide for a prolonged drug release rate from the implant and
improved antimicrobial performance.
In the study reported here, monolaurin is employed as a passive coating on
K-wires with the long-term goal of achieving reduced incidence rate of orthopaedic
implant-associated infections and decrease the burden of pin tract infections, thus
improving patient outcomes. A dip-coating technique was implemented to modify
stainless steel K-wires. Following physicochemical characterization of the coating,
the antibacterial properties of modified wires were evaluated in vitro in the model
experiments with S. epidermidis, methicillin-sensitive S. aureus (MSSA) and
methicillin-resistant S. aureus (MRSA). Furthermore, the biological effect of
monolaurin coating on osteoblasts was studied. The objective of this study was to
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demonstrate the efficacy of monolaurin-coated K-wires in vitro and provide a
foundation for further animal and clinical studies.

3.2. Materials and Methods
3.2.1. Materials. Stainless steel K-wires were obtained from Smith &
Nephew (Andover, MA). Monolaurin, HPLC grade acetonitrile, 200 proof ethanol
and phosphate buffer solution (PBS) were purchased from Sigma-Aldrich (St.
Louis, MO). Difco™ Tryptic Soy Agar and BBL™ Trypticase™ Soy Broth (TSB)
were obtained from BD (Franklin Lakes, NJ). Alpha Minimum Essential Medium
(αMEM), fetal bovine serum (FBS), penicillin and streptomycin were purchased
from Corning Inc. (Manassas, VA). MTT and LIVE/DEADâ Viability/Cytotoxicity kit
were purchased from Thermo Fisher Scientific (Waltham, MA).
3.2.2. K-wire modification. Stainless steel K-wire pieces with the length of
10 mm and the diameter of 1.575 mm were used in this study. The surface area of
the samples was calculated to be approximately 49.5 mm2 assuming cylindrical
geometry. Prior to the modification, the wires were cleaned in air plasma with the
input power of 30 W for 15 minutes. For coating, 1 ml of monolaurin solution in
ethanol (10 mg/ml) was transferred into a sterile centrifuge tube with a cleaned Kwire. After 10 min incubation, the wire was removed from the solution and air-dried
for 10 minutes at room temperature under sterile conditions. Uncoated controls
were prepared by incubating the wires in pure ethanol for 10 min followed by airdrying for 10 min, similarly to the coated wires.
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3.2.3. Characterization of the coating
FTIR analysis of the samples. FTIR spectra were collected by averaging 16
scans obtained by the FTIR spectrometer equipped with a Thermo-SpectraTech
Foundation Series Endurance Diamond ATR accessory (Thermo-Nicolet Magna
550, Waltham, MA). Scans were run at the resolution of 4 cm-1 and recorded in
absorbance units from 500 to 4000 cm-1. Baseline correction was applied to
properly determine net peak heights.
Surface morphology of the samples. Monolaurin-coated K-wires were
characterized using SEM (Hitachi S4800, Schaumburg, IL). Prior to imaging,
samples were sputter-coated with a gold film (thickness » 5-7 Å). Micrographs with
a magnification of up to 50,000X were obtained using the accelerated voltage of 5
kV and the working distance of 6 mm.
Additionally, surface morphology was characterized by AFM using MFP-3D
instrument (Asylum, Santa Barbara, CA) equipped with metal-coated AC240TS
Olympus microcantilevers with the nominal resonance frequency of 70 kHz and a
spring constant of approximately 2 nN/nm. Imaging was performed both in tapping
and force-mapping modes. Samples of uncoated and coated wires were fixed on
a glass slide using double sided duct tape. Topography of all samples was
measured in contact mode; additionally, coated samples were scratched to
measure thickness of the coating. Stickiness of the studied samples was also
analyzed by force-mapping. Precise spring constant for each of the cantilevers
was determined before each measurement.
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The thickness of the monolaurin coating was also measured using
spectroscopic reflectometry (Edmund optics, Barrington, NJ) according to the
protocol adapted from the reference [173]. For this experiment, silicon wafers
coated with monolaurin according to the procedure described in sec. 3.2.2 were
used. Measurements were conducted with the angle of incidence of 0° for the
wavelengths ranging from 400 to 900 nm. The Fresnel equation was used to fit the
acquired data. A total of 3 replicates were analyzed.
Determination of monolaurin binding yield. Coated wires were prepared
using a series of monolaurin solutions in ethanol with different concentrations (1,
2.5, 5, 6, 7.5, 10, 15 mg/ml). After 10 min incubation, each wire was carefully
removed from the solution, air-dried for 10 min and transferred to a vial containing
1 ml of anhydrous acetonitrile, where it was sonicated for 30 minutes. The
absorption spectra of the resulting monolaurin solution in acetonitrile were
recorded using UV/Vis spectrophotometer (ATi UNICAM UV-2 UV/vis, Cambridge,
UK) in the range of 190-300 nm. The amount of deposited monolaurin was
calculated from the value of absorption at 220 nm using a calibration curve (Fig.
3.1). The latter was obtained using monolaurin solutions in acetonitrile with
standard concentrations ranging from 0.1 to 10 mg/ml.
3.2.4. In vitro evaluation of antibacterial activity. The antimicrobial activity
of monolaurin-coated wires was evaluated against methicillin-sensitive S. aureus
(MSSA, ATCC® 14775), methicillin-resistant Staphylococcus aureus (MRSA,
ATCC® 33591), and S. epidermidis (ATCC® 12228).
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Studies of planktonic bacteria. Prior to the experiments, bacteria were
cultured in soy broth until they reached the stationary phase. Afterwards, the
concentration of the inocula was adjusted to 106 CFU/ml using fresh broth. Coated
and plain wires were placed into a sterile test tube containing 1 ml of 106 CFU/ml
bacterial suspension. Samples were incubated at 37°C under mild shaking.
Aliquots of bacterial suspension were taken at the following time points: 0, 1.5, 3,
4.5, 6, 7.5, 24, 48 hours. The aliquots were analyzed by the spread-plate method
according to the ISO 4833:2. Based on the data, the antibacterial efficacy was
calculated as a log reduction of bacteria. A total of 4 replicates were performed to
obtain planktonic bacteria viability curves.

Fig. 3.1. Calibration curve measured for monolaurin

Analysis of adherent bacteria. Bacterial culture with the concentration of 106
CFU/ml was prepared as described in Sec. 3.2.4. Coated and plain wires were
placed in a sterile 24-well plate; 1 ml of bacterial inoculum was added to the wells
containing the wires. In order for bacteria to adhere and form a biofilm, the wires
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were statically incubated for 48 hours at 35°C [174]. The biofilm formation was
quantified using the CV assay as described by Kobayashi et al [175]. Briefly, after
the 48 h biofilm growth period, coated and plain wires were transferred to a sterile
24-well plate, rinsed with PBS 3 times, and incubated with 0.1% aqueous solution
of crystal violet for 10 min. After the wires were washed with PBS three times, they
were placed in 33% acetic acid and incubated for 15 min under mild shaking.
Optical density of the resulting solution was measured at 590 nm using a
microplate reader (Bio-Tek Synergy HT, Winooski, VT). All experiments were
replicated 6 times.
In addition, the number of colony forming units in the biofilm was measured
according to the protocol described in the literature [176]. Briefly, after plain and
monolaurin-coated wires were exposed to the bacteria inoculum for 48 hours to
create a biofilm, each wire was gently rinsed with sterile PBS 3 times and placed
in a test tube with 1 ml of sterile PBS. To remove the adherent bacteria, wires were
vortexed for 30 s followed by sonication in an ultrasonic bath for 60 s. Colony
counting was performed for the resulting bacterial suspensions using the protocol
described previously (Fig. 3.2). A log reduction of adherent bacteria was then
calculated. Four replicates were performed for both coated and uncoated samples.
The biofilm formation was also imaged using SEM. Sample preparation for
SEM was performed using the protocol described by El Abed et al [177]. Briefly,
samples were fixed with 2.5% glutaraldehyde, followed by an additional postfixation with 1% osmium tetroxide. Then, the wires were dehydrated by successive
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exposure to an ethanol gradient (50, 75, 90, 100 %), followed by the treatment with
hexamethyldisilazane (HMDS). The samples were then sputter-coated with a layer
of gold, and the SEM images were obtained using an accelerating voltage of up to
5 kV and a working distance of 5 mm.

Fig. 3.2. The protocol used to dislodge bacteria from the surface of the wires.

Inhibition diameter test. Antibacterial activity of the wires was also evaluated
using the zone of inhibition test. Protocol for these measurements was adapted
from the literature [178]. Briefly, 106 CFU of bacteria were seeded on agar plates.
Coated and plain wires were transferred to the center of the inoculated plates and
incubated at 37°C; zone of inhibition was measured at different time points (1, 2,
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3, 4 days) as described in the literature [178]. These experiments were replicated
6 times.
3.2.5. In vitro evaluation of cytotoxicity. The analysis of cytotoxicity of
monolaurin-coated K-wires was performed in a model experiment with mouse 7F2
osteoblasts (ATCC® CRL-12557™). Cells were cultured in αMEM medium
supplemented with 10% FBS and 1% of penicillin and streptomycin at 37oC in 5%
CO2.
МТТ assay. The effect of the monolaurin coating on osteoblast proliferation
was evaluated using the MTT assay. The protocol for this experiment was adapted
from the literature [179]. Osteoblasts were passaged after reaching confluency,
and aliquots containing ~40,000 cells were transferred into a sterile 24-well plate
containing monolaurin-coated and plain wires. Samples were incubated in the
presence of cells for 2, 4 and 7 days at 37°C in 5% CO2. Following the incubation,
the wires were removed from the wells, and osteoblasts were exposed to the 5
mg/ml MTT reagent for 4 hours. Then, dimethyl sulfoxide (DMSO) was added to
completely dissolve formazan crystals, and the optical density of the resulting
solution was measured at 570 nm using a microplate reader (Bio-Tek Synergy HT,
Winooski, VT). Four replicates were performed for each of the time points.
Live/Deadâ assay. The viability of osteoblasts attached to the wires was also
assessed using Live/Deadâ assay. To achieve cell attachment, the wires were
incubated with 200 μl of osteoblast suspension (200,000 cells/ml) for 4 hours at
37°C. Then, the wires were transferred to the wells containing fresh αMEM medium
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and incubated for 4 days at 37°C in 5% CO2. After the incubation, the plain and
coated wires were removed from the medium, gently rinsed with sterile PBS 3
times, and treated with calcein AM (20μM) and ethidium homodimer-1 (4μM).
Following an incubation period of 30 min, wires were imaged using a fluorescent
microscope (Thermo-Fisher EVOS FL Auto, Waltham, MA). The viability of cells
attached to the surface of the wires was measured according to the Live/Deadâ
assay kit manual. Cells attached to tissue-grade polystyrene were used as the
control. 4 replicates were performed for this assay.
Cell visualization. Attached osteoblasts were also imaged using SEM, and
cell morphology was analyzed based on the obtained images. After cells were
allowed to attach to the wires, samples were fixed and dehydrated as described
previously. SEM images were obtained using an accelerating voltage of up to 5 kV
and a working distance of 5 mm.
3.2.6. Table of experiments. The design of experiments conducted in this
chapter are summarized in the table 3.1.
Table 3.1. Experimental design
Test samples

Micromorphology

Analysis of antibacterial activity

Monolaurin-

Analysis

Analysis

coated

of

of

planktonic

antibiofilm

bacteria

activity

SS
Kwires

SEM & AFM
Plain
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Cytotoxicity

Inhibition

MTT,

zone

Live/Dead,

test

SEM

3.2.7. Statistical analysis. All numerical data is presented as the mean
value ± standard deviation. One-way ANOVA was used for variance comparison.
Repeated measures ANOVA was used for the analysis of the zone of inhibition
experiments. Statistical difference was considered significant if P-value was less
than 0.05.

3.3. Results
3.3.1. Binding yield of monolaurin. Binding yield of monolaurin was
determined based on the adsorption isotherm of the drug on stainless steel K-wires
(Fig. 3.3). Due to the low molar extinction coefficient of monolaurin, a large error
was observed at low loading concentrations. The adsorption isotherm reached
saturation at monolaurin concentration of approximately 7.5 mg/ml.

Fig. 3.3. Adsorption isotherm of monolaurin on stainless steel K-wires. Error bars were
calculated based on the standard deviation values.
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The saturation loading was found determined to be 84±4 μg of monolaurin
per 1 cm wire, corresponding to the density of 4.3±0.2 μg/mm2. Based on these
results, 10 mg/ml monolaurin solutions were used to coat K-wires in all future
experiments to ensure saturation coating.
3.3.2. Characterization of monolaurin coating. Fourier transform infrared
spectroscopy (FTIR) was used to prove monolaurin adsorption on the K-wires. Fig.
3.4 shows the spectra collected from coated and pure monolaurin.

Figure 3.4. FTIR spectra of monolaurin-coated wire and pure monolaurin.

As can be seen, there is virtually no difference between the spectra of the
coated sample and that of the pure monolaurin. Thus, these data confirm that the
coating consists of monolaurin.
Morphological characteristics of the coating were analyzed using scanning
electron microscopy (SEM), atomic force microscopy (AFM) and spectroscopic
reflectometry. As shown in Fig. 3.5b, monolaurin-coated wires exhibit smooth
surface with minor extrusion lines. According to the micrographs, the coating is
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evenly distributed across the surface of the wire. Little to no difference can be seen
when comparing surface morphology of the plain and monolaurin-coated K wires.
Further analysis of micromorphological characteristics of the monolaurin coating
was conducted using AFM technique.

Fig. 3.5. SEM micrographs of plain (a) and monolaurin-coated (b) K-wires.

Topography images acquired by AFM (Fig. 3.6a-d) confirmed the
smoothness of monolaurin coating. Using scratching technique, the thickness of
the coating was determined to be 144±35 nm. These results are in good correlation
with those of the spectroscopic reflectometry, which showed the thickness of the
coating to be 161±57 nm. Coated samples exhibited considerably higher adhesion
force between the surface and the cantilever tip compared to the uncoated
samples (85.2±18.6 and 15.9±2.1 nN for coated and uncoated wires, respectively,
p<0.001), indicating the presence of a uniform coating (Fig. 3.6e-f).
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Fig. 3.6. Atomic Force Microscopy images of uncoated and coated samples. The topography
(a, b), cantilever deflection (c, d) and adhesion force map (e, f) of plain (a, c, e) and
monolaurin-coated (b, d, f) were acquired.
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3.3.3. Evaluation of antibacterial activity
Antibacterial activity against planktonic bacteria. The antimicrobial activity of
monolaurin-coated wires against planktonic bacteria was assessed based on the
microbial viability curves. As shown in Figs. 3.7, 3.8, coated wires were highly
efficient against MSSA, MRSA and S. epidermidis, completely eliminating
planktonic bacteria in less than 7.5 hours.

Fig. 3.7. Planktonic bacteria viability curves obtained in the presence of plain and
monolaurin-coated K-wires: (a) MSSA, (b) MRSA, (c) S. epidermidis. (d) Representative
photos of the tubes containing plain and monolaurin-coated wires incubated with the
bacteria for 48 hours. Error bars were calculated based on the standard deviation values.
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In the presence of the uncoated wires, the number of bacteria increased by
more than two orders of magnitude over the first 7.5 hours. These data suggested
that monolaurin-coated wires achieved a 6.0-log reduction of planktonic MSSA,
MRSA and S. epidermidis. One-way ANOVA was used to compare the
antimicrobial activity of monolaurin-coated and plain wires at different time points.
The significant difference (p<0.05, n=4) between coated and plain samples was
observed after 1.5 hours time point.

Fig. 3.8. Representative photos of recultivated bacteria incubated with the plain and
monolaurin-coated K-wires. (a), (c) MSSA incubated with plain wire; (b), (d) MSSA incubated
with monolaurin-coated wire; (e), (g) MRSA incubated with plain wire; (f), (h) MRSA
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incubated with monolaurin-coated wire; (i), (k) S. epidermidis incubated with plain wire; (j),
(l) S. epidermidis incubated with monolaurin-coated wire.

Antibacterial activity against adherent bacteria. The antibiofilm activity of
monolaurin coating was evaluated by the Crystal Violet (CV) assay and
quantitative analysis of adherent bacteria. The results of the CV assay are shown
in Fig. 3.9a. In the case of all three bacterial strains, the absorbance values for
coated wires were significantly lower when compared to those for the plain wires,
indicative of antibiofilm activity of monolaurin-coated wires against MSSA, MRSA
and S. epidermidis (p<<0.05, n=6).
Figs. 3.8, 3.9b show the count of adherent bacteria. Again, monolaurincoated wires demonstrated pronounced antibiofilm properties resulting in the
significant drop of the number of adherent bacteria when compared to the plain
wires (p<0.05, n=4). Monolaurin-coated wires effected a 5.7-, 5.8- and 6.0-log
reduction of adherent MSSA, MRSA and S. epidermidis, respectively. These
results are consistent with those obtained for planktonic bacteria.
The observed antibiofilm effect was additionally confirmed by SEM imaging.
As can be seen from Fig. 3.10 little or no evidence of adherent bacteria is observed
on the surface of the coated wires for all three bacterial strains studied herein. On
the other hand, a large number of adherent bacteria surrounded by extracellular
matrix are evident on the SEM images of the uncoated wires for all three strains
studied. The analysis of high magnification images (30,000X) revealed that the
morphology of bacteria adherent to the plain wires is different when compared to
those found on monolaurin-coated wires (Figs. 3.11).
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Fig. 3.9. (a) The results of crystal violet assay performed for plain and monolaurin-coated
wires in the presence of MSSA, MRSA and S. epidermidis. (b) Adherent bacterial count for
plain and monolaurin-coated wires incubated in the presence of MSSA, MRSA and S.
epidermidis for 48 h. Asterisks represent statistically significant difference between plain
and monolaurin-coated wires (p<0.05). Error bars were calculated based on the standard
deviation values.

It is evident that in the latter case, the integrity of bacterial cell wall is
disrupted, resulting in the deformation of the bacterial cell surface. In contrast, the
bacteria attached to the plain wire exhibit the conventional spherical shape.
Inhibition zone test. Additional evaluation of antimicrobial activity of
monolaurin-coated wires was performed by the inhibition zone assay. As shown in
Fig. 3.12d, coated wires were efficient against all three bacterial strains tested.
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Fig. 3.10. SEM micrographs of the bacteria lodging on the surface of plain and monolaurincoated wires. (a) S. aureus adherent to the plain wire; (b) S. aureus adherent to the
monolaurin-coated wire; (c) MRSA adherent to the plain wire; (d) MRSA adherent to the
monolaurin-coated wire; (e) S. epidermidis adherent to the plain wire; (f) S. epidermidis
adherent to the monolaurin-coated wire.
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Fig. 3.11. High-resolution SEM micrographs of the bacteria adherent to plain and
monolaurin-coated K-wires. (a) MSSA adherent to the plain wire; (b) MSSA adherent to the
monolaurin-coated wire; (c) MRSA adherent to the plain wire; (d) MRSA adherent to the
monolaurin-coated wire; (e) S. epidermidis adherent to the plain wire; (e) S. epidermidis
adherent to the monolaurin-coated wire.
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Fig. 3.12. Inhibition zone for MSSA (a), MRSA (b) and S. epidermidis (c) around monolaurincoated K-wires. (d) Representative photos of inoculated agar plates containing plain and
monolaurin-coated wires. Inhibition zone for MSSA (e), MRSA (f) and S. epidermidis (g)
around plain K-wires. Error bars were calculated based on the standard deviation values.
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The results of time-dependent antimicrobial efficacy test shown in Figs.
3.12a-c suggest that the inhibition diameter decreases significantly with time
(p=0.028, p=0.009, p=0.035, n=6 for MSSA, MRSA and S. epidermidis,
respectively, as determined by the repeated measures ANOVA). However, even
after 96 hours of incubation, monolaurin-coated K-wires were capable of inhibiting
bacterial growth for MSSA, MRSA and S. epidermidis.
Overall, results of the inhibition zone test are indicative of good prolonged
antibacterial efficacy of monolaurin-coated wires, demonstrating their ability to
inhibit growth for all three strains for at least 4 days.
3.3.4. Evaluation of cytotoxicity. The influence of monolaurin coating on
cell proliferation was assessed using the methyl thiazolyl tetrazolium (MTT) assay
(Fig. 3.13a). The image demonstrates that culturing osteoblasts in the presence of
monolaurin-coated wires did not affect cell proliferation rate: the OD570, which
indirectly corresponds to the number of cells, was not significantly different for
coated and uncoated wires at different time points (p=0.687, 0.781, 0.757, for day
2, 4, and 7, respectively; n=4).
Fig. 3.13b shows fluorescent images of osteoblasts stained with Live/Deadâ
reagents. Similarly to plain wires, monolaurin-coated wires exhibited a large
number of adherent osteoblasts, vast majority of which were found to be viable
(Table 3.1).
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Fig. 3.13. (а) The results of the MTT assay performed on osteoblasts in the presence of plain
and monolaurin-coated K-wires; (b) the viability of osteoblasts adherent to plain and
monolaurin-coated samples determined by the Live/Deadâ assay; SEM micrographs of
osteoblasts adherent to plain (c) and monolaurin-coated (d) samples; fluorescence
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microscopy images of osteoblasts lodging on plain (e) and monolaurin-coated (f) wires.
Cells stained green are viable, red staining corresponds to dead cells. Error bars were
calculated based on the standard deviation values.

Quantification of obtained results revealed that the percentage of viable cells
was not significantly different for plain (99.4±0.1 %) and monolaurin-coated
(99.4±0.1 %) wires and tissue-grade polystyrene (99.5±0.1 %), which was used as
a positive control (p=0.311, n=4).

Table 3.1. Number of viable and dead osteoblasts lodging on plain and monolaurin-coated
K-wires determined by Live/Deadâ assay.
Viable cells,
log(cell
number)
Plain
wires

5.41±4.84

Coated
wires

5.34±5.01

P-value

P=0.419,
n=6

Dead cells,
log(cell
number)
3.19±2.59

3.12±2.71

P-value

P=0.409,
n=6

Total number,
log(cell
number)
5.42±4.84

P-value

P=0.411,
n=6

5.34±5.01

The analysis of the adherent cells was performed using SEM imaging and
the Live/Deadâ assay. Figs. 3.13c-f display micrographs of the osteoblasts
adherent to the surface of plain and monolaurin-coated wires. Good cell
attachment and spread across the surface is evident from these images;
osteoblasts exhibited normal polygonal morphology with extended filopodia. Little
to no difference can be noticed when comparing plain and modified samples.
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Thus, the results of SEM imaging and the Live/Deadâ assay are in good
agreement with the results of the MTT assay, and suggest good biocompatibility
and no cytotoxicity of monolaurin-coated K-wires.

3.4. Discussion
The present work focusses on potential benefits of using monolaurin as an
antibacterial coating on orthopaedic K-wires in attempt to reduce the burden of pintract infections, in particular those caused by S. aureus (including MRSA) and S.
epidermidis.
In this study, stainless steel K-wires were coated with monolaurin using a
simple yet effective dip-coating method. The proposed methodology appears to be
fairly inexpensive and simple, and does not require the use of toxic chemical
compounds or thermal/mechanical treatment that may cause structural, chemical
or physical alterations in the implants. The “GRAS” status of ethanol and
monolaurin, the only compounds used for the manufacturing of the coated K-wires,
can facilitate the translation of modified wires into clinical practice.
Given that binding yield of monolaurin at saturation was found to be ca. 4.3
μg/mm2, the total dose of monolaurin absorbed on a 1 cm K-wire is 84 μg. Although
the antibacterial activity of monolaurin has been studied previously, there are still
debates regarding the therapeutic dose and the minimally inhibitory concentration
(MIC) of this compound. Having analyzed the antibacterial activity of monolaurin
against 29 strains of S. aureus, including MRSA, K. Holland et al. [180] determined
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that its MIC is in the range from 10 to 20 μg/ml. However, H. Preuss et al. [181]
calculated the MIC of monolaurin against S. aureus to be 62.5 μg/ml. Another study
suggests that the MIC of monolaurin against S. aureus is in the range from 25 to
50 μg/ml [182]. At the same time, we were unable to find the MIC of monolaurin
against S. epidermidis in the literature. However, the antimicrobial activity of lauric
acid against S. epidermidis is well studied: the MIC was determined to be 3.9 μg/ml
[183]. Multiple studies suggest that monolaurin has better antimicrobial properties
than lauric acid [172,182,184]. Therefore, the MIC of monolaurin against S.
epidermidis can be expected to be lower than 3.9 μg/ml. Overall, even if it is difficult
to estimate the volume of liquid to which a K-wire is exposed in vivo after the
implantation, the dose of monolaurin introduced with K-wires in this study (84 μg
per one cm of wire) is expected to provide antibacterial properties to the implants
at least during the first days after the implantation. Results of our inhibition zone
tests support this conclusion. Nonetheless, further animal studies are required to
determine if the current dose is sufficient to provide a therapeutic effect in vivo.
There is a general consensus that increased surface roughness leads to the
enhanced osteointegration, primarily due to the more developed bone-to-implant
contact [42,185]. However, in certain cases improved osteointegration can be
undesirable [186]. The use of external fixators and K-wires implies the subsequent
removal of the implants, and a more developed bone-to-implant contact would
increase frictional forces between the implant and bone upon removal, causing
severe discomfort for patients. Therefore, alterations of surface characteristics, in
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particular roughness, of external fixators and K-wires should be avoided. The
results of SEM and AFM imaging conducted herein showed that topography of the
monolaurin-coated wires was similar to that of the plain wires (Figs. 3.5, 3.6). The
only parameter that was affected by the presence of monolaurin coating is the
surface stickiness, as measured by AFM. However, an observed increase of
stickiness is not expected to affect cell adhesion and osteointegration in any way,
since those responses are guided biochemically (through adhesion proteins), not
physically. Hence, the modification of K-wires with monolaurin coating is not
anticipated to influence osteointegrative properties of the implants. One possible
issue that can be caused by the altered stickiness of the wires is their handling by
the surgeon during the implantation and removal. Here, we qualitatively tested
handling of the coated wires in a pilot experiment by using a wire to pierce a silicon
rubber Septa flask cork, and did not see any difference between handling coated
and uncoated wires. However, handling can still be an issue during the actual
surgery and will be assessed in detail during future animal studies.
The present study was primarily focused on the in vitro analysis of
antibacterial activity of monolaurin-coated K-wires. S. aureus (MSSA and MRSA)
and S. epidermidis were tested here mainly because these pathogens cause
majority of implant-associated infections. It was estimated that all existing
pathogens except for staphylococci account for only 22% of orthopaedic infections
[187]. Hence, the importance of fighting staphylococcal infection cannot be
overestimated. High activity against MRSA noticed here for monolaurin-coated

68

wires is of special interest because these antibiotic resistant strains cause the
highest morbidity and mortality.
Since most pin-site infections are caused by the formation of bacterial biofilm
on the implant surface, the modified wires are required to possess pronounced
antibiofilm activity. However, the efficacy against planktonic pathogens should also
not be underestimated. In 1987, Anthony Gristina introduced the concept called
“race to the surface” [188]. During the initial post-operative period, the host defense
system is impaired and vulnerable to the bacteria introduced during surgery.
Gristina suggested that there is a “race” to the surface of the implant between host
cells and bacteria from adjacent tissues; if the race is won by bacteria, the risk of
the implant infection increases considerably. Therefore, treatment needs to be also
directed against nearby planktonic bacteria. Given monolaurin’s low water
solubility, it is expected that coated K-wires can potentially provide prolonged drug
release upon implantation. Thus, monolaurin coating is anticipated to be effective
against planktonic bacteria.
As predicted, monolaurin-coated K-wires exhibited excellent antimicrobial
properties against planktonic MSSA, MRSA and S. epidermidis, completely
eliminating of up to 106 CFU in the case of each of these strains (Figs. 3.7, 3.8).
Monolaurin-coated wires also prevented biofilm formation, as indicated by the
results of the crystal violet staining and SEM imaging (Figs. 3.8 - 3.11). It is
important to emphasize that those few bacteria found on the surface of the
modified wires had disrupted cell walls suggesting that these microorganisms were
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not viable. Although the consensus regarding monolaurin’s mechanism of
antibacterial action has not been reached, alteration of the plasma membrane and
disruption of the bacterial cell wall is considered to be one of the two most likely
mechanisms of action [172,182]. An alternative mechanism assumes that
monolaurin is able to interfere with bacterial two-component regulatory systems.
Monolaurin was found to inhibit WalK/R, one of the 16 two-component regulatory
systems in S. aureus, leading to the death of the bacteria [189]. In this study, we
observed direct confirmation of the disruption of bacterial cell walls; however, the
second mechanism could also play a role as it was not studied here.
Since the cytotoxicity of antibacterial agents is an important issue [5], the
cytocompatibility of monolaurin-coated K-wires has been extensively studied
herein (Fig. 3.13). According to the ISO 10993, a material is considered to be
cytotoxic if cell viability in its presence drops below 70% [178]. In this study, we did
not observe evidence of any adverse effects of monolaurin on osteoblast viability;
cell viability was found to exceed 99%. The size, shape, morphology and number
of osteoblasts adherent to the surface of modified wires suggest good
biocompatibility and lack of cytotoxicity of the monolaurin coated wires. These
results were not unexpected considering known safety record of monolaurin
[172,182,190].
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3.5. Conclusions
In conclusion, monolaurin-coated Kirschner wires were manufactured, and
their performance was evaluated in vitro. Prepared wires showed pronounced
antibacterial and antibiofilm activity against methicillin-sensitive and methicillinresistant S. aureus, and S. epidermidis. Excellent biocompatibility of monolaurincoated implants was demonstrated in a mice osteoblast model. Data obtained here
serve as the foundation for further animal and clinical studies of monolaurin-coated
K-wires. Taking into account the advantages of monolaurin as an antibacterial
coating, the approach proposed in this work can have a huge potential in
orthopaedic applications.
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CHAPTER 4*
IN VITRO STUDY ON THE DETERIORATION OF POLYPROPYLENE HERNIA
REPAIR MESHES
4.1. Introduction
According to the National Center for Health Statistics nearly five million
people in the US suffer from some form of hernia, and this number is expected to
increase due to the growing prevalence of obesity [191]. Due to this, hernia repair
surgeries are among the most common operations, with over a million procedures
performed in the US annually [192].
After the introduction of polypropylene (PP) hernia repair meshes in 1958,
mesh hernioplasty became the gold standard for surgical hernia repair. Today,
hernia repair meshes are the most widely used medical implants [52]. Such
resounding success glutted and rapidly expanded the hernia repair mesh market.
However, manufacturers are often reluctant to discuss product disadvantages,
some of which lead to complications after hernia repair surgery. Chronic
postoperative pain appears to be one of the most adverse and common
complications [193]. Evidence from several sources suggests that almost 20% of
patients who undergo the surgery experience chronic postoperative pain, and the
quality of life for more than half of these patients is compromised to such an extent
that they cannot participate in daily activities [84]. Recently, the complaints became
so numerous that the FDA issued a warning about the complications associated
* Results and data provided in this chapter were previously published in:
D. Gil, J. Rex, V. Reukov, A. Vertegel. In vitro study on the deterioration of polypropylene hernia
repair meshes. Journal of Biomedical Materials Research B, Accepted manuscript.
As of 9/26/2017 DOI was not provided
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with the implantation of the prosthetic meshes [194]. Moreover, the FDA is
considering reclassifying surgical meshes from Class II to Class III products [195].
Although the mechanism of development of post-hernioplasty chronic pain
is still the subject of debate, much of the evidence points towards oxidative stress
as the key factor causing the complication [196–198]. Despite recent
improvements to the structure and design of hernia repair meshes, these implants
remain a foreign body that triggers an inflammatory response after the
implantation. Macrophages and neutrophils, which are in the vanguard of the
foreign body response, release a milieu of oxidants and enzymes that interact with
the implanted material and may cause its deterioration. A large body of evidence
suggests that reactive oxygen species (ROS), in particular superoxide and
hydroxide radicals, are capable of oxidizing the materials of the mesh [9,198,199].
It was also reported that myeloperoxidase (MPO) – the enzyme released by
neutrophils – can also facilitate mesh deterioration [200]. MPO catalyzes the
conversion of hydrogen peroxide and chloride anions to hypochlorous acid (HOCl),
a strong oxidative agent. Overall, oxidative stress at the site of implantation causes
polymeric implants to lose their structural and mechanical integrity; crystallinity and
molecular weight may also change [198]. This can result in the mechanical
stiffening and/or shrinkage of the mesh, which may ultimately lead to the
development of post-operative chronic pain [64,193,201].
It goes without saying that, depending on the material, surgical meshes may
have varying susceptibility to either MPO or ROS. Even mesh design may play a
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role in the susceptibility of a mesh to deterioration [85]. A number of recent studies
showed that effect of the oxidative stress on hernia repair meshes made of the
same material can be different, resulting in different complication rates [84,201].
Thus, in order to improve the performance of hernia repair meshes, it is of
particular importance to reveal the mechanism of their deterioration.
The vast majority of the current mechanistic studies involve analysis of the
explanted meshes [9,194,202]. However, this approach has several vital
drawbacks. In particular, since only failed meshes are subjected to analysis, there
is no positive control that can be used as a reference. Moreover, analysis of the
explanted materials implies the use of procedures to remove residual tissue, which
involve treatment in an oxidative environment [8,9,202]. This can lead to additional
physical, chemical and structural alterations, making it difficult to reveal the actual
mechanism of mesh deterioration.
In an attempt to address these limitations and provide better understanding
of the mechanism of mesh deterioration we developed in vitro methodology that
mimics aspects of the oxidative environment at the tissue-implant interface after
surgery. Based on a set of physicochemical analyses, a protocol for characterizing
the degree of oxidative damage to the meshes was developed. Such an approach
may lead to an improved understanding of the processes resulting in the structural,
physical and chemical alterations in hernia repair meshes under oxidative stress.
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4.2. Materials and Methods
4.2.1. Hernia repair meshes. In the present work, two types of hernia repair
mesh were studied: UltraPro® (Ethicon, Somerville, NJ) and Composix™ EX (Bard
Davol, Warwick, RI), which were kindly donated by the Carolinas Medical Center
(Charlotte, NC). These meshes are among the most widely used for hernia repair
and have proven their reliability and efficiency over the past years. When
compared with UltraPro®, Composix™ meshes are known to be more susceptible
to oxidative stress and more often lead to complications. This fact will be used to
evaluate the predictive power of the proposed in vitro models.
UltraPro® lightweight meshes consists of non-absorbable polypropylene
monofilament fibers and an absorbable poliglecaprone-25 monofilament portion.
Composix EX heavyweight meshes also consist of two parts: Polypropylene
BARD® Mesh on the one side to promote tissue ingrowth and submicronic
expanded polytetrafluoroethylene (ePTFE) sheet on the other side to prevent
bowel-cell adhesion to the prosthesis. As stated in the literature [9,203], Teflon™
shows outstanding biocompatibility and undergoes only minute degradation after
being implanted. Therefore, only the polypropylene portion of Composix™ meshes
was analyzed in the course of this work.
4.2.2. Oxidative deterioration of the meshes. In the present work, the
effect of reactive oxygen species (ROS) and hypochlorite (OCl-) was mimicked.
To simulate the activity of ROS towards hernia repair meshes, a previously
developed model system was utilized [204]. UltraPro® and Composix™ meshes
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were exposed to 100 ml of 1.63M H2O2 and 0.05M CoCl2 solution (Sigma-Aldrich,
St. Louis, MO). The 1.63M H2O2 solution was prepared from 35% w/w H2O2
solution (Alfa Aesar, Haverhill, MA) stabilized by 0.05% Na4P2O7•10H2O.
Additionally, glass wool (Sigma-Aldrich, St. Louis, MO) was added to the solution
to provide an additional surface for free radical generation. Samples were treated
in the oxidative medium for 40 days at 37°C. The H2O2/CoCl2 solution was
replaced every 3 days to eliminate the effect of H2O2 degradation. After the
treatment, the meshes were rinsed with 500 ml of distilled water and air-dried at
room temperature.
The effect of hypochlorite on the prosthetic mesh materials was tested
according to the protocol described elsewhere [205]. Briefly, the meshes were
treated in 100 ml of 1 mM NaOCl solution (Sigma-Aldrich, St. Louis, MO) for 40
days at 37°C. After the treatment, the meshes were rinsed with 500 ml of distilled
water and air-dried at room temperature.
4.2.3. Characterization of the meshes
Scanning electron microscopy. Micromorphological characteristics of the
treated and plain meshes were analyzed by means of a variable pressure scanning
electron microscope (Hitachi S3400, Tarrytown, NY). Samples were not coated
with a conductive material prior to the imaging. Images with a magnification of up
to 2,000X were obtained using an accelerating voltage of 20 kV and a working
distance of 7.0 – 11.3 mm. Chamber pressure was in the range of 25-50 Pa.
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Fourier transform infrared spectroscopy. Chemical alterations to the meshes
were analyzed using Fourier transform infrared spectroscopy (FTIR). Samples
were not subjected to any form of special treatment prior to the experiments and
were analyzed in toto. The spectra were obtained using a Thermo-Nicolet Magna
550 FTIR spectrometer with a Thermo-SpectraTech Foundation Series Endurance
Diamond ATR accessory (Thermo Fisher Scientific, Waltham, MA). Scans were
recorded in the range from 500 to 4000 cm-1 with a resolution of 4 cm-1. A total
number of 5 replicates were performed.
X-ray photoelectron spectroscopy. Surface composition of the meshes was
analyzed using X-ray photoelectron spectroscopy (XPS). The measurements were
conducted on a Kratos AXIS Ultra DLD spectrometer (Shimadzu, Columbia, MD)
using non-monochromatic AlKα X-radiation (1253.6 eV). Binding energy of the CC component of C1s peak was set at 285 eV and used thereafter as a standard
for the binding energy calibration. The measurements were carried out at a
pressure of 10-8 torr. Surface composition was assessed by analyzing the peaks
that correspond to C1s and O1s emissions.
Differential scanning colorimetry. The effect of oxidative stress on the
physical properties of the meshes was analyzed by means of differential scanning
calorimetry (DSC). The analysis was performed on a Q1000 DSC instrument (TA
Instruments, New Castle, DE). The samples were heated up to 200°C with a heat
rate of 20°C/min and then kept at a target temperature for 5 min. All measurements
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were performed in a nitrogen atmosphere. Onset melting temperature (Tm) and
heat of fusion (Hf) were calculated for each sample from the melting endotherms.
The degree of crystallinity (Xc) of the meshes was calculated according to
the following formula [206]:
𝑋" =

$%
$%,'((

×100%

where Hf,100 is the heat of fusion of 100% crystalline polypropylene and was
considered to be 209 J/g [206]. A total number of 4 replicates were performed for
the analysis.
Water uptake experiments. The protocol for water uptake experiments was
adapted from elsewhere [207]. The meshes were cut into small pieces (≈ 20 mg)
and kept in a desiccator for 48 hours at room temperature. Then the samples were
weighted to the nearest 0.1 mg using an AE 200 Balance (Mettler Toledo,
Columbus, OH). The meshes were then transferred to centrifuge tubes filled with
distilled water and maintained for 10 days at room temperature to reach saturation.
Following incubation, the samples were removed from water, wiped free of surface
moisture and weighed. Water uptake (WU) was calculated using the following
formula [208]:
𝑊𝑈 % = 100%×

𝑀1 − 𝑀3
𝑀3

where M0 represents the original dry weight of the sample and Mf - the weight of
the sample after being kept in water. Five replicates were performed for each of
the mesh samples.
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Tensile testing. Mechanical properties of the meshes were evaluated by
means of uniaxial tensile testing. The experiments were performed using a
Synergie 100 (MTS, Eden Prairie, MN). Pieces of the meshes (1×4 cm) were fixed
in the machine and stretched with a 5 cm/min crosshead rate until the mesh was
loaded to failure. Afterwards, stress-strain curves were plotted, and the elastic
moduli were calculated for each sample. A total number of 7 replicates were
analyzed.
4.2.4. Table of experiments. The design of experiments conducted in this
chapter are summarized in the table 4.1.
Table 4.1. Experimental design
Meshes

Micro-

Surface

Structural

Mechanical

morphology

oxidation

properties

properties

Treatment

Swelling

UltraPro

®

FTIR &
ROS
OCl

SEM
XPS

-

Tensile

Water

testing

uptake

Tensile

Water

testing

uptake

DSC

FTIR &
Composix™

ROS
OCl

-

SEM

DSC
XPS

4.2.5. Statistical analysis. Numerical data is shown as the mean value ±
standard deviation. One-way ANOVA was used for data comparison. Statistical
difference was considered significant if P-value was less than 0.05.
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4.3. Results
4.3.1. Scanning electron microscopy. SEM images provided essential
information regarding morphology of the meshes. The micrographs of untreated
UltraPro® and Composix™ meshes demonstrated that these samples exhibited a
relatively smooth surface with evidence of parallel extrusion lines, which are
introduced to the mesh fibers during the manufacturing process (Figs. 4.1a-b). In
the micrographs of the meshes treated in H2O2/CoCl2 solution, the surface of the
UltraPro® meshes remained relatively smooth, although several minor defects and
cracks were noticeable as indicated by red arrows (Fig. 4.1c). The Composix™
meshes displayed stronger evidence of deterioration: the surface exhibited a
plethora of defects in the form of deep and wide cracks that formed along the
extrusion lines (red arrows), and small holes (yellow arrows), indicative of material
degradation (Fig. 4.1d).
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®

Fig. 4.1. Microphotographs of the UltraPro and Composix™ meshes treated in H2O2/CoCl2
and NaOCl solutions: (a) – plain UltraPro

®

mesh; (b) – plain Composix™ mesh; (c) –

®

UltraPro mesh treated in H2O2/CoCl2 solution; (d) – Composix™ mesh treated in NaOCl
®

solution; (е) – UltraPro mesh treated in H2O2/CoCl2 solution; (f) – Composix™ mesh treated
in NaOCl solution
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When treated in NaOCl, the UltraPro® samples again showed a smooth
surface with few signs of deterioration, while the Composix™ meshes exhibited
major cracks and fissures, indicated with red arrows (Figs. 4.1e-f).
4.3.2. Fourier transform infrared spectroscopy. FTIR spectroscopy was
used to assess chemical alterations introduced during the treatments. The spectra
collected from the treated and plain meshes are displayed in Fig. 4.2. Peaks at
2946 - 2836, 1456 and 1375 cm-1 correspond to pristine polypropylene and can be
ascribed to the various types of C-H and C-C vibrations. Hence, these bands can
be observed on every spectrum and weren’t analyzed thereafter.

®

Fig. 4.2. FTIR spectra of UltraPro and Composix™ meshes treated in H2O2/CoCl2 (а) and
®

®

NaOCl (b) solutions: 1 - plain UltraPro , 2 – plain Composix™, 3 – treated UltraPro , 4 –
treated Composix™

Spectra of the meshes treated in H2O2/CoCl2 solution show the emergence
of several additional peaks (Fig. 4.2a). Of particular interest are bands at 1720
cm-1; indicative of the presence of carbonyl groups (C=O); these can be observed
only in the spectra of the treated samples. The intensity of these signals was not
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significantly different for treated UltraPro® and Composix™ meshes. Broad bands
at 3100-3600 cm-1 correspond to the intra- and intermolecular H-bonded hydroxyl
groups.
Fig. 4.2b shows FTIR spectra of the meshes treated in NaOCl solution. The
bands corresponding to the carbonyl groups (C=O) can also be observed on the
spectra of the treated UltraPro® and Composix™ meshes. The intensity of these
peaks was again not significantly different for treated UltraPro® and Composix™
meshes. Concurrently, no signs of hydroxyl groups were found on the spectra of
the treated samples.
4.3.3. X-ray photoelectron spectroscopy. XPS spectra were obtained to
analyze mesh surface composition before and after the treatments.
As expected, the two major elements detected by the XPS method were
carbon and oxygen (hydrogen is undetectable by XPS). Traces of silicon and
chlorine, which appear to be impurities, were also found. The obtained results
allowed for evaluation of the surface composition of the meshes by analyzing the
intensity of the peaks at 285 and 532 eV, corresponding to C1s and O1s emissions,
respectively. Fig. 4.3 displays typical low-resolution XPS spectra of plain and
treated UltraPro® and Composix™ meshes. Of particular interest were the bands
corresponding to the O1s emission. It is evident that the relative intensity of these
signals increases after both treatments. These results are indicative of surface
oxidation caused by ROS and hypochlorite.
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®

Fig. 4.3. Typical low-resolution XPS spectrum obtained for UltraPro (a) and Composix™(b)
meshes. 1 – plain mesh, 2 – mesh treated in in H2O2/CoCl2, 3 – mesh treated in NaOCl

4.3.4. Differential scanning calorimetry. DSC was used to study structural
properties of the meshes. Single cycle experiments were conducted for all
samples. Figs. 4.4a-b show the DSC thermograms collected from the pristine
UltraPro® and Composix™ meshes compared to those treated in H2O2/CoCl2
solution. The onset temperature for UltraPro® did not change significantly after the
treatment, and was 163.0±1.3°C and 161.2±1.3°C for untreated and treated mesh,
respectively (p = 0.09, n = 4). The calculated heat of fusion (Fig. 4.5a) for the
treated UltraPro® sample was found to be 84.7±5.4 J/g, whereas the value for the
pristine UltraPro® sample was calculated to be 87.9±8.2 J/g. These two values
were not significantly different (p = 0.54, n = 4). In the case of Composix™ meshes,
the onset temperature was found to be 157.2±1.1°C and 151.3±1.2°C for the
pristine and treated mesh, respectively. These temperatures were found to be
significantly different (p << 0.001, n = 4). Furthermore, the treated meshes had a
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significantly lower heat of fusion of 84.8±6.8 J/g as compared to 98.3±2.6 J/g for
the plain Composix™ mesh (p = 0.010, n = 4).

Fig. 4.4. DSC curves for the UltraPro

®

(a, c) and Composix™ (b, d) meshes treated in

H2O2/CoCl2 (a, b) and NaOCl (c, d) solutions.

Figs. 4.4c-d display the results of the DSC measurements for the meshes
treated by hypochlorite compared to those for the untreated meshes. For the
UltraPro® mesh, the onset temperatures for the plain and treated mesh were found
to be 163.1±1.3°C and 162.0±1.2°C, respectively. The difference between these
temperatures was not statistically significant (p = 0.2, n = 4). The heat of fusion for
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the plain UltraPro® mesh was 87.9±8.2 J/g, whereas the heat of fusion for the
treated UltraPro® mesh, was 84.4±4.3 J/g (Fig. 4.5b). These values were also not
found to be significantly different (p = 0.48, n = 4). In the case of the Composix™
meshes treated by hypochlorite, the onset temperatures were 157.2±1.1°C and
152.1±1.2°C for the plain and treated samples, respectively, and these values
were found to be significantly different (p = 0.001, n = 4). Similarly, the heat of
fusion for the treated Composix™ meshes (85.9±1.8 J/g) was ca 13% lower
compared to the heat of fusion for the untreated Composix™ meshes (98.3±2.6
J/g), and these two values were significantly different (p = 0.0002, n = 4).

Fig. 4.5. The onset melting temperature (a), heat of fusion (b) and crystallinity (c) of the
®

UltraPro and Composix™ meshes treated in H2O2/CoCl2 and NaOCl solutions. Dark grey
bars – plain mesh, light gray bars – mesh treated in H2O2/CoCl2; white bars – mesh treated
in hypochlorite. Asterisks demonstrate significance difference (p < 0.05, n = 4). Error bars
were calculated based on the standard deviation values.

Fig. 4.5c compares the crystallinity of the pristine and treated meshes. As
could be expected based on the observations for the onset temperatures and heat
of fusion, a significant drop in crystallinity after the exposure to ROS and
hypochlorite anions was only observed for Composix™ meshes (p = 0.009 for ROS
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treatment and p = 3*10-4 for NaOCl treatment, respectively, n = 4), but not for the
UltraPro® meshes (p = 0.53 for ROS treatment and p = 0.48 for NaOCl treatment,
respectively, n=4).
4.3.5. Water uptake experiments. Water uptake experiments were
conducted to compare the swellability of UltraPro® and Composix™ meshes. After
immersion in water for 10 days, both types of mesh reached a constant water
absorption level. The weight of the UltraPro® meshes increased by 2±1%, while
the weight of the Composix™ increased by 6±3%. Therefore, it was shown that
Composix™ hernia repair meshes absorb significantly more water when compared
to UltraPro® meshes (p = 0.022, n = 5).
4.3.6. Mechanical testing. The plain and treated meshes underwent tensile
testing to evaluate alterations in mechanical properties following the oxidative
treatments.
Typical tensile force-displacement relationships for plain and treated
polypropylene meshes are presented in Fig 4.6a. It can be noted that the forcedisplacement curves consist of two distinct regions. The first region (EI)
corresponds to the initial elastic deformations caused by the stretch of the mesh
weft. The second region (EII) corresponds to the elastic behavior of the mesh fibers
and appears to be the stiffness of the material [78]. Only these parameters were
analyzed in this work since they are relevant to the properties of the mesh material.
The stiffness values are presented in Fig 4.6b.
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Generally, oxidative treatments led to an increase in the stiffness. However,
it can be seen that the parameter for the UltraPro® meshes increased significantly
(p << 0.001, n = 7) only after the treatment in H2O2/CoCl2 solution.

Fig. 4.6. (a) Typical force-displacement curve obtained for plain and treated in H2O2/CoCl2
Composix™ mesh. (b) Stiffness of the UltraPro

®

and Composix™ meshes treated in

H2O2/CoCl2 and NaOCl solutions. Asterisks demonstrate significance difference (p < 0.05, n
= 7). Error bars were calculated based on the standard deviation values.

The Composix™ meshes showed a significant (p = 0.0001, n = 7) increase
in the stiffness in the case of both treatments. Furthermore, the parameter for
Composix™ meshes increased by more than 10-fold in the case of both
treatments, while the stiffness for the UltraPro® meshes only increased by ca 2fold.

4.4. Discussion
Modern macroporous monofilament polypropylene (PP) meshes, such as
UltraPro® and Composix™, are widely used for hernia repair surgeries. The use of
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PP prosthetic meshes in hernioplasty has become so common as a result of
general confidence in the high biocompatibility and reliability of the implants [107].
Moreover, according to multiple references, implantation of PP meshes is also
associated with a relatively low recurrence rate [209]. All these characteristics
make PP meshes the gold standard for hernia defect closure. At the same time, it
was reported that nearly 20% of patients who have undergone hernioplasty
experience chronic pain 1 year after the surgery [202,210]. The only treatment
option for those patients appears to be a revision surgery, which places an
additional burden on the patient and the healthcare system.
A growing body of evidence points to oxidative stress as a key factor in the
development of the complications associated with post-hernioplasty chronic pain
[198,211–213]. When exposed to the myriad of oxidants and enzymes after the
implantation, hernia repair meshes may undergo various structural, chemical and
mechanical changes. This can cause alterations in the mesh’s linear dimensions
[54]. It was shown that mesh shrinkage or expansion is associated with the
development of chronic pain and increased chance of the recurrent herniation
[214,215]. Moreover, mesh stiffening can lead to mechanical irritation of the
surrounding tissues, thus provoking further excessive inflammatory response [54].
However, there is a lack of consensus regarding the mechanism of hernia
repair mesh deterioration caused by oxidative stress. Analysis of failed explanted
meshes cannot fully reveal the mechanism of implant failure; this is mainly due to
the absence of a positive control and the necessity of removing tissue residues.
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One possible solution could be an in vitro model that mimics oxidative stress at the
mesh-tissue interface.
The present work focused on the influence of ROS and hypochlorite anions
on the physical, chemical and structural integrity of hernia repair meshes. The in
vitro system developed by Zhao, et al. was used herein to simulate the effect of
ROS on prosthetic meshes [216]. In a model experiment to mimic environmental
stress cracking of polyurethane elastomers, it was shown that the oxidative
medium consisting of hydrogen peroxide and cobalt (II) chloride is a reasonable
model to mimic in vivo oxidative stress conditions. In this system cobalt chloride is
added to facilitate the production of ROS according to the Haber-Weiss reaction
[217]:
H5 O5 + CoCl5 → Co<= + OH > + OH ∙
Later, Zhao et al. modified the oxidative system by adding glass wool to
enhance interactions between ROS and studied materials [204]. It was stated that
the in vitro approach precisely mimicked the in vivo oxidative environment at the
tissue-biomaterial interface [204].
In an attempt to simulate the effect of hypochlorite anions produced by
myeloperoxidase, the meshes were treated in a sodium hypochlorite solution with
a concentration of 1 mM. It is believed that this in vitro system provides a sufficient
correlation with the in vivo oxidative stress [205,218]. The hypochlorite
concentration used in the present study is somewhat similar to the local
concentration observed in natural systems at the inflammatory site [219,220]. It is
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important to emphasize that both approaches used herein to mimic the in vivo
oxidative environment at the tissue-biomaterial interface have never been applied
to study hernia repair meshes.
Better understanding of the effect of oxidative stress requires identification
of the structural, physical and chemical alterations in the meshes upon exposure
to oxidative insult. Previous experiments with gamma irradiation of polymers
revealed that three important molecular effects may occur in polyolefins in the
presence of free radicals: 1) chain branching, followed by cross-link formation; 2)
chain scissions, which can also be followed by chain cross-linking; and 3) chemical
oxidation, also resulting in cross-linking due to the formation of hydrogen bonds
between the polymer chains (Fig. 4.7) [221,222]. Our results suggest that all
meshes exposed to the oxidative media underwent these transformations.
However, the extent of the alterations was different when comparing UltraPro® and
Composix™ meshes.
The analysis of chemical oxidation of the meshes was performed using FTIR
and XPS techniques. Since both mesh types were exposed to oxidative stress, the
formation of oxygen-containing groups, particularly carboxyl groups, was likely to
occur. This assumption was supported by the data. The FTIR spectra of both
UltraPro® and Composix™ meshes, treated in either H2O2/CoCl2 or NaOCl
solutions, revealed the emergence of bands that can be ascribed to carboxyl
groups. However, signal-to-noise ratio for these bands was calculated to be ca.
2.5:1, which did not allow accurate comparison of the peak intensities. Therefore,
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XPS was used for an additional surface characterization. The results were in good
agreement with the FTIR studies, and demonstrated an increase of the oxygen
content on the surface of treated meshes, suggestive of the formation of oxygencontaining functional groups on the surface. The signal-to-noise ratio for the O1s
bands in the XPS studies was ca. 8:1. This allowed for accurate comparison of the
intensities of the peaks for different samples, and brought us to the conclusion
about a similar degree of surface oxidation for Ultrapro® and ComposixTM meshes
after the treatments. Thus, taken together, results of FTIR and XPS studies
showed the evidence of surface oxidation following oxidative treatments for both
Ultrapro® and ComposixTM meshes, and indicated that the degree of surface
oxidation was similar for both types of meshes. Therefore, we should expect similar
degree of cross-linking due to the formation of hydrogen bonds for these two
meshes.
Information about chain branching and scissions can be obtained from DSC
experiments. Our results suggest that these alterations were far more likely to
occur in the case of Composix™ meshes since the degree of crystallinity and onset
melting temperature for these meshes changed significantly after exposure to
oxidation (Fig. 4.5) [197]. At the same time, the difference between the treated and
plain UltraPro® meshes was not found to be significant. It should be noted that
onset temperature corresponds to the beginning of the phase transition, and is not
the same as the position of the peak on DSC. Typically, onset temperatures are
reported in the literature for characterization of functional polymeric materials,
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including hernia meshes, since these parameters correlate better with the degree
of crystallinity [197].

Fig. 4.7. Molecular effects occurring in polyolefins when exposed to oxidative insult

It is known that under oxidative conditions, chain branching and chain
scissions may lead to the formation of cross-links between the polymer chains
[9,194]. In addition, these processes may lead to the increase of the number of
polymer chain entanglements [223]. These structural alterations often result in an
increased stiffness of the material [9,194]. The results of the mechanical testing
conducted in the present work indirectly confirmed the formation of cross-links and
chain entanglements in the studied meshes. The tensile testing experiments
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demonstrated a significant increase of the stiffness of the Composix™ meshes that
have undergone the treatment in H2O2/CoCl2 and NaOCl solutions. At the same
time, mechanical properties of the UltraPro® meshes changed only after being
exposed to ROS, though the extent was much lower than with Composix™
meshes. Concurrently with increase of the stiffness of the treated meshes, the EI
region of the samples decreased substantially following exposure to the oxidative
insult. Apparently, this effect is due to excessive deterioration of the regions of
mesh filament entanglements, which largely determine the EI region of the forcedisplacement curves. High degradation of these regions of hernia meshes was
demonstrated for the implants exposed to the oxidative insult [197]. Although, this
effect was not assessed in this work, future studies should involve analysis of the
degradation of mesh entanglement regions.
In combination, the results of our studies indicate that mesh stiffening upon
oxidation is unlikely to be caused by cross-linking due to the formation of new
hydrogen bonds, but rather is caused by polymer branching and/or chain scissions
leading to polymer chain cross-linking. Future studies of molecular weight
distributions of polypropylene before and after oxidative treatment may help to
elucidate the exact mechanism of the oxidative mesh stiffening.
All the molecular effects described above may lead to micromorphological
alterations of the mesh surface. Scanning electron microscopy was used herein to
evaluate these changes. In good agreement with the previous results, Composix™
meshes

exposed

to

ROS

or

NaOCl
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exhibited

more

pronounced

micromorphological alterations. These results are also in agreement with those
obtained for the explanted polypropylene hernia repair meshes that also
demonstrated

cracks,

extrusion

lines

and

holes

on

the

surface

[9,194,196,202,224]. The surface of treated UltraPro® meshes remained smooth
with barely noticeable signs of deterioration.
Thus, the obtained results suggest that Composix™ meshes are more
susceptible to oxidative stress when compared with UltraPro® meshes. This effect
can be explained by the results of water uptake experiments. We have shown that
Composix™ meshes are capable of absorbing significantly (p = 0.022, n = 5) more
water than UltraPro® meshes. The increased absorption of water during swelling
provides a passage for water soluble oxidants, thus enhancing oxidation and the
formation of chain scission and cross-link domains in the Composix™ hernia repair
meshes.

4.5. Conclusions
In the present work, we compared the susceptibility of Composix™ and
UltraPro® meshes to in vitro oxidative challenge. The meshes were subject to two
model treatments that mimic in vivo effects of reactive oxygen species and
hypochlorite anions. It was found that both treatments increased the stiffness of
the meshes. We speculate that such changes in mechanical properties are caused
by formation of cross-links between the polymer chains, chain scissions, and
hydrogen bonds between the carboxyl groups introduced to the materials. We
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have demonstrated that Composix™ meshes, when compared with UltraPro®
meshes, were more vulnerable to the oxidative stress caused by either reactive
oxygen species or hypochlorite anions. This is in agreement with clinical
observations of lower incidence of chronic postoperative pain in the case of the
UltraPro® meshes.
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CHAPTER 5*
ANTI-INFLAMMATORY COATINGS ON HERNIA REPAIR MESHES
5.1. Introduction
Hernia repair surgeries are among the most common operations with over
20 million procedures performed worldwide each year [192]. The use of polymeric
mesh in incisional hernioplasty was first proposed in 1958 by Dr. Usher [52]. Since
then, insertion of prosthetic implants became a well-established procedure for
reinforcing the closure of hernia defects. Polypropylene is commonly used in the
construction of these meshes as it possesses several vital characteristics such as
high chemical inertness and strong ability to integrate with surrounding tissues,
resulting in relatively low inflammatory response. Because of these properties,
polypropylene has become the most commonly used mesh for hernioplasty
worldwide. Nevertheless, mesh-related complications continue to be observed
after hernia repair surgeries. Recurrences, seroma formation, adhesions,
infections and bowel obstruction have been observed [225]. Post-operative chronic
pain is of particular importance since nearly 30% of the patients have to deal with
this problem [84].
While exact mechanism of development of chronic pain still remains a
subject of debate, a growing body of evidence points towards oxidative stress as
one of the major factors leading to the implant deterioration and chronic
postoperative pain in hernioplasty [194,197,226]. It was reported [227,228] that
* Results and data provided in this chapter were previously published in:
D. Gil, J. Rex, W. Cobb, V. Reukov, A. Vertegel. Anti-inflammatory coatings of hernia repair
meshes: a pilot study. Journal of Biomedical Materials Research B, 2017, 00B:000–000,
DOI:10.1002/jbm.b.33834
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reactive oxygen species (ROS), in particular superoxide and hydroxide radicals,
cause the most harm to the material of the mesh. It was also shown [196,226] that
hypochlorite ions (OCl-) produced by enzyme myeloperoxidase present in
neutrophils can contribute to the process of oxidative degradation of the implant.
This suggests that oxidative stress plays a crucial role in the development of
complications following hernia repair surgeries.
Within the past few years, several strategies aiming to reduce the prevalence
of complications were developed. For instance, clinical studies showed that hostsite integration can be drastically enhanced by using hernia repair meshes with
large hexagonal pores [85]. Other works demonstrated that altering mesh density
affects the healing process after the surgery: lightweight hernia repair meshes
were shown to reduce tissue adhesion and improve tissue integration compared
to heavyweight meshes [84,201]. However, these approaches yielded only
incremental improvements in long term outcomes of hernioplasty. Moreover,
reducing the polypropylene content of meshes has weakened their structure and
led to cases of central mesh fracture [229].
One promising strategy to reduce complications could be the use of surface
coatings on hernia repair meshes. Expanded polytetraflouroethylene mesh has
been coated with silver chlorhexidine in an effort to provide bactericidal activity.
This coating has shown to kill species of Staphylococcus aureus and methicillinresistant S. aureus out to 14 days [230]. Omega-3 fatty acid has been used on
polypropylene mesh to reduce inflammation and tissue adhesions when compared
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to a reference mesh [136]. The use of coatings was found to be highly efficient,
being hailed as one of the “the most important incremental advances for mesh
design” [136]. However, omega-3 fatty acid can alter the handling characteristics
of the mesh, which poses a problem for laparoscopic repairs where the mesh is
introduced through a trocar. Additionally, there are concerns with a higher
incidence of postoperative infections [231]. As such, the search for a safe and
efficient anti-inflammatory coating is of a great importance for the field.
Vitamin E, which refers to a family of tocopherols and tocotrienols, is a wellknown and potent anti-oxidant. Vitamin E was tested as a drug candidate for
treatment of a number of conditions, in which oxidative stress plays important
pathophysiological role, such as Amyotropic Lateral Sclerosis, Alzheimer’s
syndrome, arthritis, asthma, kidney and liver diseases, and stroke [232]. It showed
efficacy in a number of animal models for these conditions, and in clinical trials as
a supplemental treatment of rheumatoid arthritis [233] and asthma [234]. While
use of vitamin E has not been studied extensively in hernia repair, one study found
that intraperitoneal injection of vitamin E following implantation of a hernia mesh
reduced the number of peritoneal adhesions in a rat model [235]. Furthermore,
poor solubility of vitamin E in water can be expected to result in an enhanced
adsorption onto hydrophobic meshes and provide a sustained release rate for a
prolonged period of time. Additionally, Vitamin E is generally recognized as safe
(GRAS) by the FDA, which can facilitate translation of vitamin E-coated meshes
into clinical practice.
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Herein, we have hypothesized that coating hernia repair meshes with
Vitamin E will lead to а reduced inflammatory response and reduced formation of
connective tissue in the vicinity of the mesh, improving the long-term outcomes of
the hernia repair surgery. Hence, the goal of this work was to evaluate in vivo antiinflammatory and anti-adhesive properties of Vitamin E-coated polypropylene
hernia repair meshes. We also endeavored to replicate the retromuscular repair
which is becoming increasingly popular in humans for ventral hernia repair with
mesh.

5.2. Materials and Methods
5.2.1. Hernia repair meshes. Prolene® polypropylene mesh (Ethicon Inc., a
Johnson & Johnson company, Langhorne, PA) was kindly donated by the
Carolinas Medical Center (Charlotte, NC) and used in the course of this study. This
type of implant is a heavyweight non-absorbable mesh with a density of 80 g/m2.
The specific surface area of the meshes was determined by low-temperature
nitrogen adsorption using Brunauer–Emmett–Teller (BET) analysis and was
calculated to be 3.4 m2/g. Heavyweight polypropylene mesh was chosen because
this implant exhibits a noticeable inflammatory response. For in vitro experiments
1 x 1 in. square samples were cut using sterile metal scissors. For animal studies
3 x 3 cm square pieces were cut and re-sterilized under UV radiation for 60 minutes
prior to implantation.
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5.2.2. Preparation of vitamin E-coated meshes. Vitamin E (Sigma-Aldrich,
St. Louis, MO) was dissolved in 95% medical grade ethanol (Sigma-Aldrich, St.
Louis, MO). 10 ml of the solutions with different vitamin E concentrations were
transferred into a 6-well plate containing pieces of surgical mesh in each well.
Samples were incubated overnight in the dark at 8oC. Meshes were then retrieved
and air-dried overnight in the dark at room temperature.
In order to determine binding yield of vitamin E, its solutions with
concentrations of 5, 10, 50, 100 and 200 mg/ml were prepared and used to coat
the meshes. After the samples were coated with vitamin E and air-dried, they were
transferred to pure 95% ethanol and incubated overnight in the dark at 8oC in order
to reach adsorption-desorption equilibrium. 100 µl aliquots of wash solutions were
collected and analyzed by measuring optical density at 292 nm using a microplate
reader (Bio-Tekâ Synergy™ III). Concentrations of vitamin E in wash solutions
were determined using a standard curve, and the amount of vitamin E absorbed
on the meshes was calculated from these concentrations assuming complete
removal of vitamin E from the surface. In order to validate this assumption, the
amount of absorbed vitamin E was measured after the mesh was removed from
wash solution. It was shown that only negligible amount of a-tocopherol remained
on the mesh. Adsorption experiments were replicated 4 times.
5.2.3. Mechanical testing. Mechanical testing of plain and modified meshes
was performed using an MTSâ Synergie™ 100 machine with a 100 N load cell. 4
pieces of plain and modified mesh, 2 x 4 cm each, were clamped to the machine
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and stretched with the rate of 50 mm/min until the sample failed. Following testing,
fore-displacement curves curves were plotted; tensile strength and structural
stiffness were calculated.
5.2.4. In vitro determination of vitamin E release profile. After adsorption
experiments were carried out, 100 mg/ml vitamin E solution was used to coat the
implants, as this concentration was considered to be optimal for further studies.
For drug release experiments, vitamin E-coated meshes were incubated in 10 ml
of 10% bovine serum albumin (BSA) solution in PBS buffer at 37oC. To determine
release kinetics, samples were taken from the BSA solution at different time points
(1, 2, 4, 7, 10 days). Concentration of remaining vitamin E was determined by
measuring optical density at 292 nm, as described in sec. 5.2.2. All experiments
were replicated 4 times.
5.2.5. Animal study. One 13-week old male New Zealand white rabbit was
used in this study. For the pilot animal experiment, a rabbit model was chosen,
since rabbits are large enough to accommodate 2 pieces of mesh sufficiently
separated. The weight of the animal was approximately 3200 g. All animal
experiments were conducted according to the protocol approved by institutional
animal care and use committee of Clemson University (AUP-2015-019). The rabbit
was hosted in Godley-Snell Animal Facility at Clemson University and treated
according to the established standards. Prior to the surgery, the animal was
anesthetized using acepromazine 1 mg/kg, ketamine HCL 33 mg/kg, atropine
0.02-0.05 mg/kg, and buprenorphine 0.05 mg/kg.
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After skin asepsis, a 5-cm incision was made in the midline of the animal’s
ventral abdominal wall. The abdominal cavity was carefully entered along the linea
alba. Just lateral to the linea alba, the posterior fascia was incised to the level of
the rectus muscle. The posterior sheath was then carefully peeled off of the rectus
muscle laterally. At the semilunar line, the dissection transitioned to the plane
between the transversus abdominis and internal oblique muscles laterally. An
intermuscular plane was created to accommodate a 3x3 cm piece of mesh (Fig.
5.1).

Fig. 5.1. Mesh implantation procedure.

The posterior sheath was then re-approximated in the midline with 4-0
polydioxanone suture in a running fashion. One sample of a Vitamin E-coated and
an uncoated Prolene® mesh were implanted into the rabbit on either side,
symmetrically with respect to the linea alba. Of note, coated meshes were not
sticky and their handling was not different from uncoated meshes. The mesh
pieces were secured to the muscle inferiorly at the four corners with 4-0
polydioxanone suture. The anterior fascia was then closed in the midline with 4-0
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polydioxanone suture in a running fashion. Skin was sutured with 3-0
polydioxanone sutures.
5.2.6. Mesh explanation and histological evaluation. 5 weeks following
the surgery, the rabbit was euthanized and tissue-mesh explants were excised in
toto. Explanted specimens contained fascia, mesh, abdominal muscles and skin.
After being processed, each sample was embedded in paraffin and 10 µm sections
were cut using a microtome.
Both foreign body granuloma and intra-pore spaces were subjected to
histological analysis. For this purpose, slides were stained with hematoxylin and
eosin (H&E), picrosirius red, Masson’s trichrome and Movat’s pentachrome,
followed by observation under light microscope. A modified histological scale was
created based on [193] and ISO 10993-6 (table 5.1). Inflammatory response was
assessed by counting the number of macrophages and Foreign Body Giant Cells
(FBGCs)

surrounding

the

meshes.

Collagen

organization,

fibrosis,

neovascularization and fatty infiltrates were examined and graded by an
independent experienced histologist in a blinded manner. Slides stained with
picrosirius red were observed through crossed polars in order to analyze the
structure of collagen frameworks. Selected areas were examined using ImageJ
software (NIH, Bethesda, MD). Hue analysis was performed based on the
methodology described in [236]. Briefly, 256 hues were divided into 2 groups. The
first group (hue range 0 – 49) was ascribed to mature collagen bundles; the second
group with a range of 50 – 100 was attributed to immature collagen fibrils. Using
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the software, the number of pixels in each group was computed and percent
volume fraction of each type of collagen was calculated.
Table 5.1. Histological scoring system
Response

0

Collagen
organization

None

Fibrosis

None

Neovascularization

None

Fatty infiltrate

None

1
Minimal
organization
Narrow band
Minimal
capillary
proliferation
Minimal
amount of
fat

Score
2
Mild
organization
Moderately
thick bands

3
Moderate
organization

4
Wellorganized
Extensive
bands

Thick bands

Mild amount
of capillaries

Moderate bands
of capillaries

Abundant
vascularity

Mild amount
of fat

Broad/elongated
fatty infiltrates

Severe
fatty
infiltrates

5.2.7. Table of experiments. The design of experiments conducted in this
chapter are summarized in the table 5.2.
Table 5.2. Experimental design

Mesh

Type

Prolene™

Plain
Vitamin
Ecoated

In vitro
experiments
Sample
characterization
Drug yield, drug
release,
mechanical
testing, ORAC

Animal experiments
Cellular
response

Tissue
characterization

Collagen
characterization

H&E

H&E, Masson’s,
Movat’s stainings

Picrosirius red

5.2.8. Statistical analysis. All numerical data is presented as mean value ±
standard deviation. Student’s t-test and one-way ANOVA was used for variance
comparison. Statistical difference was considered significant if P-value was less
than 0.05. Statistical analysis was performed using Excel (Microsoft, Redmont,
WA).
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5.3. Results
5.3.1. Mechanical properties of the meshes. Results of mechanical testing
are presented in table 5.3. Structural stiffness and tensile strength of the coated
and plain meshes were determined for five replicates and were not found to be
significantly different (p = 0.18 and 0.38, respectively).
Table 5.3. Mechanical properties of plain and vitamin E coated meshes
Vitamin E-coated
Plain mesh

P-value
mesh

Stiffness, N/mm

5.5 ± 0.4

4.6 ± 1.1

0.18

Tensile strength, N

1.1 ± 0.1

1.2 ± 0.3

0.38

5.3.2. Binding yield of vitamin E. Fig. 5.2 shows binding yield for vitamin E
on a 1x1 in. piece of Prolene® mesh from ethanol solutions with different initial drug
concentrations. The amount of Vitamin E loaded on the mesh increases with the
concentration of the initial solution for concentrations up to 100 mg/ml (p<0.0001,
n=4). For higher initial concentrations the coating was sticky, and some vitamin E
was draining from the mesh upon storage. This made controlled loading difficult
for initial concentrations higher than 100 mg/ml. Thus, loading for all further
experiments was performed using initial vitamin E concentration of 100 mg/ml.
5.3.3. Vitamin E release profile. A vitamin E release profile was evaluated
in the presence of BSA, to model presence of protein solution in the vicinity of the
implant in vivo. Fig. 5.3 shows the release profile for a coated mesh incubated in
10% protein solution.
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Fig. 5.2. Binding yield of vitamin E on polypropylene hernia repair mesh (n = 4). Error bars
were calculated based on the standard deviation values.

Fig. 5.3. In vitro release profile of vitamin E from coated meshes after the exposure to 10%
BSA solution (n = 4). Error bars were calculated based on the standard deviation values.

A significant drop of bound Vitamin E was measured after 10 days of
incubation in BSA (p = 0.1, n=4). However, it was shown that approximately 70%
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of Vitamin E still remained on the mesh. These results indicate that a-tocopherol
adsorbed on the implant can potentially provide a prolonged release profile in vivo.
5.3.4. Wound healing. The rabbit successfully survived until the end of the
experiment. The linea alba healed well; no indications of wound dehiscence,
infections, or any other complications were observed.
5.3.5.

Histological

evaluation.

Histopathological

examination

was

performed to assess inflammation, capsule formation, neovascularization, fatty
infiltration and collagen composition. Plain and vitamin E - coated meshes showed
different levels of host tissue response.
First, H&E staining was used to assess inflammatory and FBGC response,
as well as the presence of fatty infiltrates and neovascularization in the vicinity of
the implants (Fig. 5.4).

Fig. 5.4. Representative photomicrographs of histological slides stained with H&E at 40x.
Asterisks show the area where mesh fibers were originally present. (A) Polypropylene mesh
coated with vitamin E. (B) Plain polypropylene mesh.

The number of macrophages infiltrated in the tissue surrounding the implants
is shown in table 5.4. It can be seen that the number of macrophages in the case
of the plain sample was significantly larger compared to the drug-coated implant
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(p<0.0001, n=11). Concurrently, little evidence of foreign body giant cells was
found in either of the implants. Compared to vitamin E-coated mesh, plain mesh
displayed a significantly larger amount of fatty infiltrates. Moreover, a significantly
higher level of neovascularization was found around the plain mesh when
compared to vitamin E-coated implant.
Table 5.4. Number of macrophages infiltrating mesh-tissue interface
Cell type
Macrophages

Number of cells per high powered (400 x) field
Plain mesh

Vitamin E – coated mesh

23 ± 4

13 ± 4

Movat’s staining was used to visualize host fibrotic response to the implants.
As predicted, both meshes induced the formation of fibrin bundles (Fig. 5.5), which
are very densely packed and are found surrounding the implants (peri-filamentous)
rather than within intra-pore space. At the same time, there was a noticeably
smaller amount and density of fibrin bands surrounding vitamin E-coated mesh.
Masson’s trichrome staining was used to assess tissue ingrowth in terms of
collagen deposition and organization. Fig. 5.6 depicts microscopic evaluation of
stained tissues around both of the implants. Collagen bundles were deposited in
both peri-filamentous and intra-pore spaces. Furthermore, collagen surrounding
both of the meshes appears to be loosely packed with empty inter-fiber spaces. At
the same time, it can be seen that each mesh displays different level of collagen
content as well as organization. Plain mesh is encompassed by much thicker
collagen capsule. Fibrotic response to the uncoated mesh possesses a
significantly higher level of organization—collagen fibers appear more aligned
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when compared with the coated implant. Moreover, Vitamin E-coated mesh is
surrounded by a higher content of elastin fibers (red/pink areas) when compared
with the plain implant.

Fig. 5.5. Photomicrographs of histological slides stained with Movat’s trichrome at 40x.
Asterisks show the area where mesh fibers were originally. Broad bands stained bright red
represent fibrin. Dark areas represent elastin fibers and nuclei. (A) Polypropylene mesh
coated with vitamin E. (B) Plain polypropylene mesh.

Fig. 5.6. Photomicrographs of histological slides stained with Masson’s trichrome at 40x.
Asterisks show the area where mesh fibers were originally. Bands stained blue represent
collagen. Red areas represent elastin and muscle tissues. (A) Polypropylene mesh coated
with vitamin E. (B) Plain polypropylene mesh.

In order to perform semi-quantitative histological evaluation, the modified
histological grading scale shown in table 1 was used. Stained slides were
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examined and graded by an experienced independent histologist in a blinded
manner. The qualitative observations described above were confirmed by the
histological score: when compared to vitamin E-coated mesh, plain mesh
demonstrated a significantly greater degree of collagen organization, fibrosis,
neovascularization and fatty infiltrates (Fig. 5.7).

Fig. 5.7. Semi-quantitative histological assessment of the tissue surrounding plain and
Vitamin E coated meshes. Histopathological score was obtained for the following
parameter: collagen organization, fibrosis, neovascularization and fatty infiltrates. Asterisks
represent statistically significant difference between plain and Vitamin E coated meshes
(p<0.05, n=12). Error bars were calculated based on the standard deviation values.

Due to the wound healing process and the inflammation associated with it,
collagen characteristics, in particular the ratio of mature to immature collagen, can
be altered when compared to the normal tissue. Picrosirius red staining (PSR) was
used to analyze the maturity of collagen surrounding the implants. Since collagen
is a strongly anisotropic molecule it appears to be birefractive. Its birefringent
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properties depend on several factors, such as maturity of fibers, package density,
fiber alignment and thickness. Generally, mature collagen (MC) possesses
stronger birefringence when compared with immature collagen (IC). Picrosirius red
molecules also appear to be elongated and, when attached to collagen, enhance
its birefringency. Due to this, mature collagen fibers, which are thick, aligned and
densely packed, possess strong birefringent properties (intensified by PSR) and
colored yellowish-orange or dark under polarized light. At the same time, immature
fibers, which are loose and contain procollagens as well as intermediate collagens,
appear greenish under polarized light. Fig. 5.8 shows images of histological slides
stained with PSR for plain and coated mesh.

Fig. 5.8. Photomicrographs of histological slides stained with picrosirius red at 40x. Pictures
were made through crossed polars. Asterisks show the area where mesh fibers were
originally. Green areas correspond to immature collagen. Yellowish and dark areas are
ascribed to mature collagen. (A) Polypropylene mesh coated with vitamin E. (B) Plain
polypropylene mesh.

Fig. 5.9 shows the ratio of mature and immature collagen in the vicinity of
the meshes calculated using the hue analysis. The mean percentage of mature
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collagen (MC) surrounding plain mesh was calculated to be 57.3 ± 6.9%; the mean
value for immature collagen (IC) was equal to 42.6 ± 6.9%, corresponding to the
ratio of 1.34 ± 0.44. Collagen content in the tissue around vitamin E-coated mesh
showed a higher percentage of mature fibers (69.0 ± 6.1%), while the percentage
of immature collagen reduced to 31.0 ± 6.1%. The resulting MC/IC ratio was equal
to 2.22 ± 0.81. The difference between the MC/IC ratios for coated and plain
meshes was found to be statistically significant (p=0.004, n=12).

Fig. 5.9. The ratio of mature and immature collagen in the tissue surrounding plain and
Vitamin E coated mesh. Asterisk represents statistically significant difference between plain
and Vitamin E coated meshes (p=0.004, n=12). Error bars were calculated based on the
standard deviation values.

Increased percentage of IC results in the formation of non-polymeric soluble
collagen, which, according to the previous studies, can lead to the deterioration of
biomechanical properties of abdominal wall [237].

113

5.4. Discussion
In 1958, Dr. Francis Usher introduced polyethylene for the reinforcement of
hernia defects. This synthetic polymer provided several advantages over the
metallic meshes, which were available at the time. The prospective evaluation of
tissue repair versus mesh hernioplasty by Dr. Luijendijk and colleagues
established an improved outcome in hernia repair with the use of synthetic mesh
[238]. Over time, many different types of hernia repair mesh were introduced.
Unfortunately, none of the hernia repair meshes is without disadvantages, resulting
in a complication rate of approximately 30% [191]. Some of the complications,
including chronic pain, tissue adhesion and recurrence, are closely related to
oxidative stress. Recently, it was shown that antioxidants are highly effective
against oxidative stress occurring during inflammation [211,212]. Thus, coating
hernia repair meshes with antioxidant agents could be a useful strategy to reduce
the rate of post-surgical complication [239]. In this part of the dissertation we
focused on potential benefits of using vitamin E as a coating for hernia repair
meshes to reduce host-tissue response following hernioplasty.
Vitamin E refers to a family of 8 tocopherols and tocotrienols, which have
similar structure with different degree of methylation. These compounds are widely
used antioxidants and known to possess pronounced anti-inflammatory properties
[232]. a-tocopherol and g-tocopherol are the two major forms of vitamin E in
mammals. It was shown that these tocopherols possess the strongest antiinflammatory properties in both animal and clinical studies [232,240]. Furthermore,
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vitamin E has been successfully incorporated into implants, including titanium
orthopedic implants, UHMWPE acetabular liners, breast implants, tympanostomy
tubes and dialysis membranes[241–244].
Although all tocopherols are able to reduce inflammation, the mechanism of
their anti-inflammatory action can vary. Studies conducted with a-tocopherol (a-T)
showed that this compound is able to inhibit protein kinase C (PKC), which is
responsible for activation and transcription of several pro-inflammatory molecules,
such as IL-1b and cyclooxygenase [245]. Reduced PKC activity leads to the
decreased phosphorylation of the NADPH oxidase subunit p47phox, which, in turn,
reduces the production of superoxide (O2-) in human monocytes and neutrophils
[245]. Similarly, a-tocopherol was found to inhibit PKC in platelets leading to
reduced cell aggregation [246]. Along with PKC, a-T down-regulates protein
kinase B (Akt) [247], which is responsible for production of pro-inflammatory
markers; Akt also controls a variety of downstream effectors, such as nuclear
factor - kB (NFkB). This factor plays a crucial role in regulating the expression of
various pro-inflammatory stimuli. It was demonstrated that a-T can drastically
decrease the adhesion of various types of cells by inhibiting NFkB and, as a result,
reducing the expression of several integrins such as CD11a, CD11b, and CD11c
[248]. Thus, it can be expected that a-T possesses anti-adhesion properties, and
such characteristics were in fact confirmed in the literature [249,250].
Taking into account all the background data along with vitamin E known
safety record, it appears to be an excellent candidate for anti-inflammatory
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coatings on hernia repair meshes. Slow release of poorly water-soluble vitamin E
directly to the implant site could improve its ability to reduce host response to the
implants.
In this work, a 3 x 3 cm piece of Prolene® mesh was coated with vitamin E
and implanted in a rabbit model. Since 100 mg/ml vitamin E solution was initially
used and binding yield of tocopherol was calculated to be »6 mg/in2, the total dose
of vitamin E adsorbed on the implant was »9 mg. According to the majority of the
reports in the literature, tocopherols are typically administrated orally [232,240].
The therapeutic dose of vitamin E in a coating has not yet been established.
However, Yetkin et al. [235] reported that intraperitoneal injection of 10 mg of
vitamin E provides therapeutic effect in a rat hernia implant model. Assuming
physiological concentration of vitamin E to be around 1 mg/dl [251], 9 mg of atocopherol introduced with the hernia repair implant in this study was expected to
provide a reasonable local therapeutic dose, even assuming an incomplete (30%)
release rate observed in a 10 day in vitro experiment.
The first 10 days following the surgery were identified as the most crucial
period in terms of the long-lasting success of the implantation [235]. Therefore, the
anti-inflammatory coating has to be stable, which requires that there is a sufficient
amount of drug absorbed on the implant both during and after the ten-day period.
Lack of stability is the major drawback of passive coatings, which reduces their
efficacy when compared to active coatings [239]. The in vitro drug release profile
for vitamin E-coated meshes showed that almost 70% of vitamin E remain
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adsorbed on the mesh even after incubation in BSA solution for 10 days. Such a
prolonged release rate is not unexpected since vitamin E is poorly soluble in water.
These results indicate that a-tocopherol absorbed on the implant can potentially
provide a prolonged release profile in vivo. Since oxidative stress is mostly caused
by macrophages and neutrophils in the vicinity of the implant, prolonged drug
release to the surrounding tissues is expected to suppress the inflammatory
response and improve long-term outcomes of the surgery.
Elastic modulus and tensile strength of hernia repair meshes are of particular
importance, since impaired mechanical properties can lead to mesh failure. Thus,
we evaluated the effect of the coating on the mechanical properties of the meshes.
According to the results of tensile testing, neither elastic modulus nor tensile
strength of the implants were affected by the presence of vitamin E coating.
As the purpose of this research was to compare the tissue response to plain
and a-tocopherol - coated meshes, histopathological analysis was of particular
importance. Both implants demonstrated significantly different host response. The
plain implant appeared to induce greater inflammatory response, as indicated by
the larger number of macrophages infiltrating mesh-tissue interface. At the same
time, there was no significant difference in FBGC response between the two
implants.
Compared to vitamin E-coated mesh, the plain sample contained more fatty
infiltrates, which correlates with enhanced connective tissue deposition and poor
implant

biocompatibility

[252].

Also,
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a

significantly

higher

level

of

neovascularization was found around the plain mesh. On the one hand, adequate
neovascularization indicates normal tissue integration and good biocompatibility of
an implant, which is beneficial [253]. On the other hand, it was shown that
excessive vascularization is often an indication of decreased biocompatibility
[193]. Furthermore, increased neovascularization can be caused by an excessive
host tissue response due to elevated level of vascular endothelial growth factor
[254].
The uncoated implant was surrounded by heavier fibrosis and collagen
encapsulation when compared to the vitamin E-coated mesh. According to the
literature, highly organized collagen and heavy fibrosis encompassing hernia
meshes are undesirable since it may lead to implant shrinkage and could also be
correlated with the incidence of adhesions [64,255].
Analysis of the collagen framework at the surgical site was of particular
interest since biomechanical strength in wound tissue, in many ways, is defined by
collagen architecture and organization. After the first incision is made, fibroblasts
that are recruited to the injury site begin secreting procollagen, which has high
levels of lysine and proline. These amino acids, upon hydroxylation, are converted
to hydroxylysine and hydroxyproline, which facilitate the transition of procollagen
to tropocollagen. Collagen forms when several tropocollagen molecules become
aligned and strong cross-links are created, increasing the tensile strength of the
entire structure. When the maturation phase of healing begins, these immature
collagen fibers are aligned towards tension lines, become thicker and more
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compact, and the stability of the framework drastically increases, forming mature
collagen. There are many factors, which may compromise fibrillogenesis, for
instance cigarette smoking, genetic influence or activity of macrophages and
neutrophils during acute phase of inflammation [237]. These aspects can alter the
IC to MC ratio, increasing the percentage of disorganized collagen fibers, which
may result in the formation of non-polymeric soluble collagen. This results in a
deterioration of the biomechanical properties of the transversus abdominus
aponeurosis. D. DuBay et al. [256] showed that it can lead to the decrease of
abdominal wall compliance, as well as unequal distribution of pressure inside the
abdominal cavity. In this study, an increased content of IC in the vicinity of the plain
mesh was observed compared to the vitamin E-coated mesh. The observed effect
can be closely related to the reduced inflammatory response associated with the
implantation of modified hernia repair mesh. Based on the discussion above,
higher MC/IC ratio could be beneficial and is expected to reduce the incidence rate
of post-surgical complications.
Study described in this chapter has several limitations. The most important
one is that only a single-animal pilot experiment was conducted. Although we
showed indications that Vitamin E-coated mesh improves wound healing process
following hernioplasty, single animal experiments cannot provide enough statistical
data to support the claim. Multiple animal experiments are required to provide
meaningful relationships among Vitamin E coating and host-body response.
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Therefore, we conducted 5-animal experiment according to the protocol described
in sec. 5.2.2, 5.2.5-5.2.8.
We used H&E staining to evaluate macrophage response towards the plain
and Vitamin E-coated meshes. One-way ANOVA was used for statistical analysis
of the obtained data. Mean values of the macrophage count obtained for each
animal were treated as independent and used for the comparison of Vitamin Ecoated and plain meshes. The results are shown in table 5.5.
Table 5.5. Macrophage response towards the studied meshes as assessed in the 5-animal
experiment

1 rabbit
2 rabbit
3 rabbit
4 rabbit
5 rabbit
Average

Number of cells per high powered (400 x) field
Plain
Coated
Mean
St.dev.
Mean
St.dev.
31
5
22
4
23
4
17
3
37
4
31
5
48
5
31
5
28
5
21
3
32
9
25
6

N

P-value

6
6
6
6
6
5

0.023
0.015
0.045
0.0001
0.018
0.015

When compared with the plain mesh, a significant drop in the number of
macrophages around the Vitamin E-coated mesh was observed (p = 0.015, n=5).
These results are indicative of the reduced inflammatory response towards Vitamin
E-coated meshes.
H&E and Masson’s stainings were used to characterize newly-formed
tissues in the vicinity of the implanted meshes. Semi-quantitative characterization
of neovascularization, fatty infiltrates and collagen organization was conducted by
an experienced histologist in a double-blinded manner according to the grading
rubric provided in sec. 5.2.5. (table 5.1). The results are demonstrated in table 5.6.

120

Table 5.6. Semi-quantitative histological assessment of the tissue surrounding plain and
Vitamin E coated meshes as assessed in the 5-animal experiment
Parameter

Collagen
organization

Neovascularization

Fatty infiltrates

1 rabbit
2 rabbit
3 rabbit
4 rabbit
5 rabbit
Average
1 rabbit
2 rabbit
3 rabbit
4 rabbit
5 rabbit
Average
1 rabbit
2 rabbit
3 rabbit
4 rabbit
5 rabbit
Average

Histological score
Plain
Coated
Mean
St.dev.
Mean
St.dev.
2.3
0.3
1.8
0.2
2.6
0.3
2.1
0.1
2.3
0.3
2.0
0.1
2.2
0.3
1.8
0.3
2.6
0.6
1.9
0.3
2.3
0.3
1.9
0.2
2.1
0.5
1.7
0.3
2.4
0.3
1.7
0.2
2.3
0.4
1.8
0.3
2.0
0.3
1.7
0.2
2.4
0.4
1.9
0.4
2.2
0.3
1.7
0.2
2.3
0.3
1.6
0.2
2.5
0.6
1.7
0.3
2.5
0.3
2
0.3
2.2
0.3
1.6
0.2
2.5
0.5
2.1
0.4
2.4
0.3
1.8
0.3

N

P-value

6
6
6
6
6
5
6
6
6
6
6
5
6
6
6
6
6
5

0.04
0.03
0.09
0.02
0.03
0.02
0.021
0.031
0.022
0.033
0.021
0.015
0.04
0.047
0.075
0.02
0.33
0.01

It is important to underline that for the rabbit #3 there was no significant
difference (p>0.05, n=6) in terms of fatty infiltrates and collagen organization when
comparing plain and Vitamin E-coated meshes. However, when comparing all 5
animals, there was a significant difference in case of all 3 histological parameters
assessed in this part of the study. Vitamin E-coated mesh was found to be
surrounded by tissues with a significantly lower degree of collagen organization
when compared with the plain mesh. Moreover, significantly higher levels of
neovascularization and fatty infiltrates were observed in the vicinity of the plain
mesh as compared with the Vitamin E-coated implant. As discussed above, these
effects are indicatives of an improved healing process in the case of Vitamin E-
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coated mesh. Therefore, results of the 5-animal experiment are in good agreement
with those of a single-animal experiment discussed above. At the same time,
addition studies are required to support the claim that Vitamin E coating affects
collagen architecture and decreases fibrotic response following hernioplasty.

5.5. Conclusions
In conclusion, Vitamin E-coated hernia repair meshes were produced, and
their performance was evaluated in vitro and in vivo. It was found that use of an atocopherol - coated mesh reduced the inflammatory response when compared to
a plain polypropylene implant. Subsequently, the reduced inflammatory response
positively affected the healing process. Thus, data obtained herein serve as a
foundation for further animal and clinical studies of tocopherol – coated hernia
repair meshes.
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CHAPTER 6
CONCLUSIONS AND RECOMMENDATIONS FOR FUTURE STUDIES
Over the past decades, many strategies to address the high incidence rate
of postoperative complications related to medical implants have been developed.
However, despite recent progress, post-surgical complications continue to be an
important problem. In the present dissertation, we focused on developing novel,
more effective approaches to prevent and treat common complications. In
particular, the scope of this study was concentrated on the infections following
orthopaedic surgeries, as well as chronic pain after hernia repair surgeries.
The first part of this work was focused on the prevention and treatment of
orthopaedic implant–associated infections. Here, Kirchner wires were chosen as a
model orthopaedic implant, as K-wiring procedures are often associated with a
high incidence rate of infections. We proposed to coat the wires with a monolaurin
– compound with the pronounced antibacterial activity against various pathogens.
Comprehensive antibacterial studies showed excellent antimicrobial activity of the
monolaurin coating against MRSA, MSSA and S. epidermidis—three pathogens
that account for more than 80% of pin-site infections. At the same time, monolaurin
coating exhibited little to no cytotoxicity to osteoblasts and excellent
biocompatibility, which was shown to be the Achilles' heel of many antimicrobial
agents currently used. Taking into account the obtained results, the approach
proposed in this work can have a huge potential in orthopaedic applications.
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At the same time, additional cell culture studies are required to fully evaluate
the biocompatibility of the monolaurin coating. When implanted, K-wires are in
contact with osteoblasts, fibroblasts and epithelial cells. Therefore, studies with
epithelial cells and fibroblasts are necessary to assess the potential cytotoxicity of
the monolaurin coating. Besides that, future studies should focus on three aspects:
1) drug loading increase; 2) the control of drug release kinetics; 3) the increase of
the mechanical stability of the coating. The latter objective is particularly important,
since many orthopaedic implant are exposed to the high shear stress during
implantation. Thereby, the coating should be mechanical robust to withstand high
shear stress. This can be done by incorporating therapeutic compounds into a
polymeric matrix. Moreover, this approach promises the control over drug release
kinetics, as well as the optimization of drug loading. Finally, animal studies are
necessary to evaluate the antibacterial activity of the monolaurin coated K-wires,
as well as the foreign body response towards the modified implants.
In the second part of the dissertation we addressed the incidence of
postoperative chronic pain following hernia repair surgeries. We focused on the
susceptibility of polymeric hernia meshes to the oxidative stress. Here,
Composix™ and UltraPro® meshes were analyzed. In order to mimic natural body
response to foreign objects we used two model systems that simulate the effect of
reactive oxygen species and myeloperoxidase on hernia repair meshes. We
showed these treatments cause substantial alterations of chemical, structural and
physical properties of the meshes. For instance, mesh stiffening was observed.
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We believe that this is due to the formation of various types of cross-links between
polymer chains. Moreover, we have shown that Composix™ meshes are more
susceptible to reactive oxygen species and hypochlorite anions when compared
with UltraPro® implants, which is in a good agreement with clinical observations.
This supports the predictive power of the model systems used in this study.
Future studies should focus on two major objectives: 1) additional
physicochemical characterization of the treated meshes; and 2) analysis of the
most widely used hernia repair meshes. The former objective is important for
supporting the proposed mechanism of hernia mesh deterioration. In particularly,
more detailed quantitative study of mesh surface composition should be conducted
by means of high-resolution XPS. This allows accurate evaluation of the chemical
groups that are introduced due to the oxidative stress. Moreover, additional
mechanical measurements should be conducted. In the present work, we analyzed
mesh stiffness using conventional tensile testing. However, this test does not
expose meshes to the physiologically relevant types of mechanical loading. Future
studies should involve ball burst testing, which was shown to better mimic in vivo
loadings applied to hernia repair meshes [224]. Furthermore, environmental stress
cracking experiments can provide a better insight on the mechanism of hernia
mesh degradation. In the present work, meshes were not exposed to the
mechanical stress while treated in the oxidative media. Future studies should
assess the synergetic effect of statistic/dynamic mechanical loadings and oxidative
insult. In addition, the analysis of a broad range of hernia repair meshes available
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on the market should be performed using the methodology proposed in this work.
The goal of this experiments is to rank hernia repair implants according to their
susceptibility to oxidative stress. This will provide useful information for surgeons
in selecting the appropriate implants for hernia repair surgeries.
The third part of the study focused on the mitigation of inflammation following
hernia repair surgeries. We proposed to modify polypropylene hernia repair
meshes with a Vitamin E-coating. A pilot animal study was conducted to evaluate
the efficacy of the proposed approach. Based on the histopathological analysis,
we observed that a-tocopherol-coated mesh induced less inflammatory response
when compared to the plain implant. Therefore, the Vitamin E-coating positively
affected the wound healing process, potentially improving the outcomes of hernia
repair surgery.
Future studies should involve the analysis of the effect of Vitamin E coating
on collagen architecture and fibrin content in the newly-formed tissues. Moreover,
additional animal studies are required to assess the short- and long-term effects
of a Vitamin E-coating. In the present study, we evaluated host-tissue response 5
weeks after the surgery. The effect of Vitamin E on an acute inflammatory
response should also be assessed. This is generally done by explanting meshes
within a few days after the initial surgery, and conducting histological evaluations.
Moreover, long-term integration of the modified meshes and the presence of
chronic inflammation should be evaluated by explanting the samples 6 months
after the surgery.
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Vitamin E coating was shown to positively affect the healing process by
reducing the inflammatory response. At the same time, mitigation of the body’s
inflammatory response can potentially make Vitamin E-coated meshes more
susceptible to postoperative infections. Therefore, animal studies employing
bacteria-challenged models are necessary to evaluate the potential effect of
Vitamin E coating on the infection incidence rate.
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